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SUMMARY 
 1 
SUMMARY 
Posttranslational modifications by ubiquitin and ubiquitin-like proteins (UBLs) are of 
fundamental relevance for cellular function, regulation and development. Besides 
ubiquitin itself, the small ubiquitin-like modifier (SUMO) is one of the best-
characterized UBLs. Protein modification by SUMO affects hundreds of cellular 
substrates and is crucial for the regulation of diverse physiological processes, 
including transcription, replication, chromosome segregation and DNA repair. 
Interestingly, SUMOylation has emerged as a predominantly nuclear modification but 
a number of cytosolic substrates have also been identified. By contrast, in the 
compartmentalized environment of the cell, not all proteins are accessible to SUMO 
enzymes. For instance, many organellar proteins such as luminal ER and 
intramitochondrial proteins are hidden from SUMOylation upon sorting. Particularly 
mitochondrial proteins are, however, often imported in a posttranslational manner. It 
is therefore conceivable that such proteins become SUMOylated at cytosolic stages 
of biogenesis. Nevertheless, the question, whether proteins transported into 
mitochondria are indeed SUMO substrates in vivo has not been experimentally 
elucidated so far. 
 Using a mass spectrometry-based approach, our laboratory identified multiple 
potential SUMO substrates annotated as mitochondrial proteins. Following up on 
these initial discoveries, I provide here a first in-depth characterization of 
mitochondria-targeted proteins as SUMO substrates. By analyzing the SUMOylation 
of individual proteins in direct assays, I could confirm that multiple mitochondrial 
matrix proteins are indeed modified by SUMO in vivo. The modification of these 
substrates is mediated by the SUMO E3 ligases Siz1 and Siz2 and targets both 
consensus and non-consensus SUMOylation sites. Consistent with the current 
understanding of the SUMO system, SUMOylation of mitochondria-targeted proteins 
is independent of their mitochondrial targeting sequences, strongly suggesting that 
the modification occurs prior to import. SUMO conjugation to mitochondria-targeted 
substrates is regulated by cytosolic HSP70 chaperones of the SSA subfamily, which, 
remarkably, not only influence the levels of SUMOylated substrates but also alter 
their modification in terms of site selectivity. Moreover, SUMOylated mitochondrial 
precursor proteins strongly accumulate in proteasome mutants and substrates 
conjugated by an isopeptidase-resistant SUMO variant are efficiently degraded in a 
proteasome-dependent manner. Thus, this study not only identifies mitochondria-
targeted proteins as a novel and unprecedented group of SUMO substrates but also 
reveals an intriguing function of SUMO in cellular protein quality control. 
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1 INTRODUCTION 
1.1 Protein modification by ubiquitin family proteins 
Posttranslational modifications (PTMs) regulate protein function, stability and 
localization and thus greatly expand the functional diversity of the proteome. PTMs 
typically refer to the covalent attachment of small functional groups (e.g. phosphate, 
acetyl or methyl groups), fatty acids, isoprenoids or sugars to substrate proteins. A 
special class of posttranslational modifiers is the family of ubiquitin and ubiquitin-like 
proteins (UBLs) (Kerscher et al., 2006; van der Veen and Ploegh, 2012). Ubiquitin 
family proteins possess a highly conserved three-dimensional structure, the ubiquitin 
or β-grasp fold, and besides ubiquitin include the small ubiquitin-like modifier 
(SUMO), Rub1 (Nedd8), Atg8, Atg12, Urm1, Hub1, ISG15, UFM1, FAT10 and FUB1 
(Kerscher et al., 2006). Most UBLs function as covalent modifiers and are typically 
attached to lysine residues of substrate proteins. One remarkable exception is the 
lipid modifier Atg8, which is covalently conjugated to the phospholipid 
phosphatidylethanolamine (Ichimura et al., 2000). Different from canonical UBLs is 
the protein Hub1, which acts by non-covalent binding to specific interaction partners 
(Ammon et al., 2014; Luders et al., 2003; Mishra et al., 2011). 
1.1.1 Ubiquitin conjugation and deconjugation 
Ubiquitin is synthesized de novo in the form of inactive precursor proteins. These 
ubiquitin precursors include linear polymers, in which ubiquitin units are arranged in a 
head-to-tail orientation (product of the UBI4 gene in S. cerevisiae) (Ozkaynak et al., 
1987) and single ubiquitin molecules fused to the N-terminus of ribosomal proteins 
(products of the UBI1-3 genes in S. cerevisiae) (Finley et al., 1989). Consequently, 
the generation of free ubiquitin requires dedicated C-terminal hydrolases that 
catalyze the proteolytic processing of ubiquitin precursors. Notably, this type of 
maturation not only produces single ubiquitin molecules but also exposes the 
C-terminal double-glycine motif required for conjugation. 
 Ubiquitin conjugation to substrate proteins (referred to as ubiquitylation) 
involves a series of three enzymatic reactions (Hershko and Ciechanover, 1998) 
(Figure 1). First, an ATP-driven ubiquitin-activating enzyme (E1) forms a high-energy 
thioester bond between its active-site cysteine residue and the C-terminal carboxy 
group of ubiquitin. Second, ubiquitin is transferred to the catalytic cysteine of a 
ubiquitin-conjugating enzyme (E2) by a transesterification reaction. Third, ubiquitin is 
covalently attached to substrate proteins. Ubiquitylation typically involves the 
formation of an isopeptide bond between the C-terminal carboxy group of ubiquitin 
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and the ε-amino group of a lysine residue in the substrate protein. However, it has 
been reported that in some cases ubiquitin is conjugated to the N-terminus or 
alternative amino acid residues of substrate proteins (cysteine, serine and threonine) 
(Breitschopf et al., 1998; Shimizu et al., 2010). 
 Ubiquitin transfer to substrate proteins is catalyzed by ubiquitin ligases (E3), 
which are categorized into two classes (Figure 1). HECT ubiquitin E3 ligases contain 
a catalytic cysteine residue and form an E3-ubiquitin thioester intermediate before 
ubiquitin is attached to the substrate (Scheffner et al., 1995). RING and RING-like E3 
ligases rather function as adaptor or scaffold proteins that bridge the ubiquitin-
charged E2 and the substrate protein, thereby promoting the direct transfer of 
ubiquitin from the E2 to the substrate (Deshaies and Joazeiro, 2009). 
 
 
 
Figure 1. Ubiquitin conjugation and deconjugation. Ubiquitin (Ub) conjugation to substrate proteins 
involves a cascade of multiple enzymatic reactions. First, ubiquitin is translated in form of inactive 
precursor proteins, which comprise linear ubiquitin polymers and single ubiquitin molecules fused to 
ribosomal proteins of the large (Rpl) and small (Rps) ribosomal subunits. Ubiquitin precursors are 
processed by dedicated ubiquitin C-terminal hydrolases (UCH), which generate free ubiquitin moieties 
exposing the crucial double-glycine (GG) motif at their C-termini (1). Ubiquitin is then activated by a 
ubiquitin-activating enzyme (E1), which utilizes the chemical energy of ATP to form a high-energy 
thioester bond between its catalytic cysteine (C) residue and the C-terminus of ubiquitin (2). Next, 
ubiquitin is transferred to the catalytic cysteine residue of a ubiquitin-conjugating enzyme (E2) (3). 
Ultimately, ubiquitin ligases (E3) catalyze the covalent attachment of ubiquitin to lysine (K) residues of 
substrate proteins (4). Ubiquitin E3 ligases are categorized according to their reaction mechanisms used 
for ubiquitin transfer. HECT E3 ligases contain an active-site cysteine and form a thioester intermediate 
with ubiquitin prior to substrate ubiquitylation. RING and RING-like E3 ligases rather function as adaptor 
proteins that bridge the substrate protein and the ubiquitin-charged E2 in a suited orientation. Ubiquitin 
E3 ligases can catalyze the modification of substrate proteins with single ubiquitin moieties or 
polyubiquitin chains. Ubiquitylation is reversible and diverse deubiquitylating enzymes (DUBs) mediate 
the deconjugation of ubiquitin from substrate proteins (5). 
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 Besides the modification with a single ubiquitin moiety (monoubiquitylation), 
substrate proteins can be simultaneously modified at multiple attachment sites 
(multiubiquitylation). Moreover, in many cases, substrate proteins are modified by 
polyubiquitin chains (polyubiquitylation) (Kerscher et al., 2006). Polyubiquitin chains 
are assembled by sequential steps of ubiquitin conjugation to an internal lysine 
residue (K6, K11, K27, K29, K33, K48 or K63) of a previously attached ubiquitin 
molecule. This results in the formation of polyubiquitin chains with specific linkage 
types, topologies and functions (Komander and Rape, 2012; Yau and Rape, 2016). 
 Similar to other PTMs, ubiquitin conjugation to substrate proteins is a 
reversible process and can be counteracted by various deubiquitylating enzymes 
(DUBs) (Komander et al., 2009). 
1.1.2 Ubiquitin-dependent protein degradation 
Since its discovery in the mid-1970s (Goldstein et al., 1975), ubiquitin has been 
implicated in the regulation of virtually all physiological processes. A major function of 
ubiquitylation is, however, to mark proteins for degradation by the 26S proteasome. 
Selective protein degradation by this multi-subunit self-compartmentalizing protease 
(Baumeister et al., 1998) is essential in all eukaryotes and plays critical roles in 
multiple cellular pathways including cell cycle regulation, signal transduction, protein 
quality control, endocytosis and antigen presentation (Varshavsky, 1997). 
 Canonical marks that label proteins for degradation by the proteasome are 
K48-linked polyubiquitin chains (Chau et al., 1989). Consistent with this crucial 
function, K48-linkages are the most abundant linkage type in vivo and strongly 
accumulate upon proteasome inhibition (Kaiser et al., 2011; Kim et al., 2011; Peng et 
al., 2003; Xu et al., 2009). However, other linkage types, for instance in form of K11- 
(Jin et al., 2008; Matsumoto et al., 2010; Williamson et al., 2009) and K29-linked 
polyubiquitin chains (Johnson et al., 1995; Koegl et al., 1999), can also trigger 
proteasomal degradation. Moreover, although predominantly implicated in non-
proteolytic pathways, K63-linked polyubiquitin chains have been reported to mediate 
protein degradation in some cases (Saeki et al., 2009). 
 Protein degradation by the 26S proteasome requires the specific recognition 
of ubiquitylated substrates by ubiquitin receptors. This can occur via two different 
mechanisms. First, ubiquitin modifications are recognized by receptor proteins that 
are stably associated with the proteasome. Examples are the ubiquitin-binding 
proteins Rpn10 (Deveraux et al., 1994; Elsasser et al., 2004; van Nocker et al., 1996) 
and Rpn13 (Husnjak et al., 2008), which act as canonical subunits of the 
26S proteasome. Both Rpn10 and Rpn13 directly bind ubiquitylated proteins via a 
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ubiquitin-binding domain (UBD). Second, ubiquitin-modified proteins are delivered to 
the proteasome by so-called shuttling ubiquitin receptors. These receptors bind 
ubiquitylated substrates via a ubiquitin-associated (UBA) domain and reversibly 
interact with the proteasome via a ubiquitin-like (UBL) domain. Canonical members 
of the group of shuttling ubiquitin receptors include Rad23 (hHR23a/b in humans) 
(Elsasser et al., 2004; Rao and Sastry, 2002), Dsk2 (Ubiquilin 1/2 in humans) 
(Funakoshi et al., 2002; Rao and Sastry, 2002) and Ddi1 (Elsasser and Finley, 2005; 
Kaplun et al., 2005). 
After delivery to the proteasome, ubiquitin-modified substrates are 
deubiquitylated by proteasome-associated DUBs (Leggett et al., 2002; Verma et al., 
2002), unfolded and guided into the proteolytic cavity for degradation into smaller 
peptides (Elsasser and Finley, 2005). 
Apart from the proteasome, clearance of ubiquitylated proteins is also 
mediated by autophagy, a cellular degradation system that delivers cytoplasmic 
material to the lysosome (in mammals) or the vacuole (in yeast) (Khaminets et al., 
2016; Mizushima et al., 2011). Importantly, ubiquitin-selective autophagy requires 
specific adaptor proteins that link the ubiquitin system to the autophagy pathway 
(Khaminets et al., 2016; Kraft et al., 2010; Rogov et al., 2014). These adaptors bind 
ubiquitylated cargo via specific UBDs and known examples include the proteins p62 
(SQSTM1) (Pankiv et al., 2007), NBR1 (Kirkin et al., 2009a; Kirkin et al., 2009b) and 
Tollip (Lu et al., 2014) in humans as well as Cue5 in yeast (Lu et al., 2014). 
Interestingly, although p62 and NBR1 preferentially interact with K63-linked 
polyubiquitin chains, all adaptors bind K48-linked polyubiquitin chains as well (Kirkin 
et al., 2009b; Lu et al., 2014). Thus, pathway choice between autophagic and 
proteasomal degradation might not solely rely on the topology of the polyubiquitin 
chains attached to a substrate. 
 A further common feature of autophagy adaptors is their ability to bind the 
autophagy factor Atg8 (LC3 and GABARAP in humans) on the autophagosomal 
membrane via so-called Atg8-interacting motifs (AIMs), which are also referred to as 
LC3-interacting regions (LIRs) (Kirkin et al., 2009a; Lu et al., 2014; Pankiv et al., 
2007). Atg8 is generally required for autophagosome formation but also serves as 
docking module for adaptors during selective autophagy. Thus, by direct recognition 
of substrates via ubiquitin-binding domains and interacting with Atg8 via AIMs, 
ubiquitin-Atg8 adaptors specifically mediate the delivery of ubiquitylated cargo for 
autophagic degradation. Remarkably, substrates of ubiquitin-selective autophagy are 
diverse and include ubiquitylated aggregates, midbody rings, organelles and even 
bacteria (Khaminets et al., 2016). 
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1.1.3 SUMO conjugation and deconjugation 
One of the best-studied UBLs besides ubiquitin is the small ubiquitin-like modifier 
(SUMO). Unicellular organisms and lower eukaryotes often express a single SUMO 
isoform (e.g. Smt3 in S. cerevisiae), whereas vertebrates and plants typically 
possess multiple genes encoding different SUMO isoforms (e.g. SUMO1-4 in H. 
sapiens) (Flotho and Melchior, 2013). All SUMO isoforms are synthesized as inactive 
precursors, which carry C-terminal peptide extensions of variable length (2-11 amino 
acid residues). Proteolytic maturation of these SUMO precursors is carried out by 
SUMO-specific enzymes that remove the amino acid residues C-terminal to the 
characteristic double-glycine motif of SUMO (Gareau and Lima, 2010). 
 Similar to ubiquitin, SUMO is usually attached to the ε-amino group of lysine 
residues in substrate proteins (referred to as SUMOylation) (Figure 2). Biochemically, 
SUMOylation highly resembles the activation and conjugation of ubiquitin. However, 
it requires a set of unique, SUMO-specific enzymes including a heterodimeric E1 
(Aos1/Uba2 in S. cerevisiae and SAE1/SAE2 in H. sapiens) and the single E2 Ubc9 
(Johnson, 2004). In many cases, SUMO-modified lysines are embedded within the 
core consensus motif ΨKX(D/E) in which Ψ is a hydrophobic amino acid (usually I, L 
or V) and X is any amino acid (Gareau and Lima, 2010). This motif can be directly 
bound by Ubc9 and does not essentially require an E3 enzyme for modification 
(Bernier-Villamor et al., 2002). However, in most cases, efficient SUMOylation is 
strongly dependent on E3 ligases in vivo. Many SUMO E3 ligases are members of 
the Siz/PIAS protein family and harbor a characteristic Siz-PIAS-RING (SP-RING) 
domain related to the RING domain of the corresponding class of ubiquitin E3 ligases 
(Gareau and Lima, 2010). The SP-RING family of SUMO E3 ligases comprises four 
proteins in S. cerevisiae (Siz1, Siz2, Mms21 and the meiosis-specific Zip3) and six 
proteins in H. sapiens (PIAS1, -2, -3, -4, ZMIZ1 and NSE2). Moreover, several other 
proteins with SUMO E3 ligase activity (RanBP2, Pc2, MUL1, TOPORS, HDAC4, -7, 
TRAF7, FUS, RSUME, MAPL) have been described in higher eukaryotes (Jentsch 
and Psakhye, 2013). 
 In many cases, SUMO substrates are modified by single SUMO moieties 
attached to one or multiple lysine residues (monoSUMOylation and 
multiSUMOylation). However, particular SUMO isoforms such as Smt3 in yeast 
(Bencsath et al., 2002) or SUMO2/3 in human cells (Tatham et al., 2001) can also 
form polySUMO chains (polySUMOylation). Formation of such polySUMO chains 
requires internal SUMOylation consensus sites, which are mainly localized within the 
N-terminus of SUMO (e.g. K11, K15 and K19 of Smt3). Other SUMO isoforms like 
human SUMO1 do not harbor N-terminal SUMOylation consensus sites and form 
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polySUMO chains with much lower efficiency in vitro (Tatham et al., 2001). However, 
hybrid chains of SUMO1 and SUMO2/3 have been reported to form via non-
consensus sites (Cooper et al., 2005; Matic et al., 2008; Pedrioli et al., 2006). 
 Protein modification by SUMO is reversible and can be regulated by SUMO-
specific isopeptidases (Figure 2). Notably, some of these enzymes not only act as 
isopeptidases but also possess a C-terminal hydrolase activity, which is required for 
the initial proteolytic maturation of SUMO precursors. All bona fide SUMO 
isopeptidases described to date are cysteine proteases and include the proteins Ulp1 
and Ulp2 in yeast and six Ulp orthologs in H. sapiens (sentrin-specific proteases 
SENP1-3 and 5-7) (Hickey et al., 2012). Moreover, recent studies have reported the 
identification of three further SUMO isopeptidases in human cells, deSUMOylating 
isopeptidase 1 (DeSI-1), DeSI-2 (Shin et al., 2012) and ubiquitin-specific protease-
like 1 (USPL1) (Schulz et al., 2012). 
 
 
 
Figure 2. The SUMO conjugation and deconjugation system of S. cerevisiae. SUMO (Smt3 in 
S. cerevisiae) is translated as inactive precursor protein in which the C-terminal double glycine motif is 
followed by a peptide extension of several amino acids (ATY in S. cerevisiae). SUMO maturation and 
exposure of the C-terminal double glycine (GG) motif is mediated by SUMO-specific isopeptidases that 
possess a C-terminal hydrolase activity (Ulp1 in S. cerevisiae) (1). Mature SUMO is then activated by a 
dimeric SUMO-activating enzyme (E1) (Aos1/Uba2 in S. cerevisiae), which utilizes the chemical energy 
of ATP to form high-energy thioester bond between the active-site cysteine (C) of one subunit (Uba2) 
and the C-terminus of SUMO (2). Subsequently, SUMO is transferred to the catalytic cysteine (C) of the 
SUMO conjugating enzyme Ubc9 (3). Eventually, SUMO E3 ligases catalyze the covalent attachment of 
SUMO to the lysine (K) residue of a substrate protein (4). Protein modification by SUMO is reversible 
and the isopeptide bond between SUMO and a substrate protein can be hydrolyzed by SUMO-specific 
isopeptidases (Ulp1 and Ulp2 in S. cerevisiae) (5). 
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1.1.4 Molecular consequences of SUMOylation 
Protein modification by SUMO affects a multitude of cellular substrates and regulates 
a large variety of physiological processes. Interestingly, SUMO substrates are 
typically modified to only a small percentage at steady state and only a very limited 
number of proteins appear to be quantitatively SUMOylated (Geiss-Friedlander and 
Melchior, 2007). However, low-level SUMOylation can sometimes entail strong 
effects, and, for instance, alter the localization, activity or stability of a modified 
protein. 
 Although the functions of protein SUMOylation are diverse and in many cases 
substrate-specific, the direct mechanistic consequences of SUMO modifications are 
mostly based on a few common molecular principles. First, SUMOylation can affect 
protein properties by competing with other lysine-directed PTMs for the same 
acceptor site. Competition between SUMOylation and ubiquitylation for the same 
amino acid residue has been reported for the protein IκB-α (Desterro et al., 1998). 
SUMO modification of IκB-α at Lys 21 blocks the ubiquitylation of this particular 
lysine residue and thereby interferes with the ubiquitin-dependent proteasomal 
degradation of the protein. A further example is a SUMO switch regulating the 
transcriptional activator myocyte-specific enhancer factor 2A (MEF2A). SUMOylation 
blocks the acetylation of MEF2A and thereby interferes with the transcriptional 
activation of the protein (Shalizi et al., 2006). 
 Second, SUMOylation can interfere with protein-protein interactions by 
shielding interaction surfaces present on a substrate protein. A well-studied example 
is the yeast DNA sliding clamp proliferating cell nuclear antigen (PCNA). PCNA is 
SUMOylated at Lys 127, which is located in close proximity to a surface area of 
PCNA that is recognized by PCNA-interacting proteins (PIP) via so-called PIP boxes 
(Moldovan et al., 2006). Accordingly, SUMO modification of PCNA at this particular 
lysine residue inhibits the binding of the PIP box-containing acetyltransferase Eco1 
and thereby negatively regulates cohesion establishment during S phase. 
 Third, SUMOylation can recruit interaction partners to a modified substrate by 
providing an additional binding interface. Non-covalent binding of proteins to SUMO 
is typically mediated by short hydrophobic peptide stretches referred to as SUMO-
interacting motifs (SIMs). SIMs harbor the core consensus sequence [V/I]-X-[V/I]-[V/I] 
and are sometimes flanked by acidic amino acid residues or phosphoacceptor sites 
(Hecker et al., 2006; Song et al., 2004; Stehmeier and Muller, 2009). Because SIM-
containing proteins bind a specific surface patch on SUMO (e.g. comprising amino 
acid 35-55 in S. cerevisiae Smt3) with typically moderate affinities (Kerscher, 2007), 
SUMOylation often fosters interactions between proteins that already possess low 
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affinities for each other. A prominent example for the SUMO-dependent recruitment 
of a specific binding partner is once more PCNA. In addition to the modification at 
Lys 127, PCNA becomes SUMOylated at Lys 164 during S phase of the cell cycle 
(Hoege et al., 2002). The modification at this particular lysine residue facilitates 
recruitment of the SIM-containing helicase Srs2 to the replication fork, where Srs2 
inhibits unwanted recombination events by disassembling Rad51 nucleoprotein 
filaments (Papouli et al., 2005; Pfander et al., 2005). 
 Notably, SUMO-SIM interactions can also occur in an intramolecular fashion. 
One example is the DNA repair protein thymine DNA glycosylase (TDG) (Steinacher 
and Schar, 2005). SUMOylation of TDG at Lys 330 leads to a conformational 
change, which is caused by an interaction of the attached SUMO moiety and a SIM 
of TDG itself. This structural rearrangement alters the DNA-binding properties of 
TDG and thereby releases this protein from chromatin. 
 A particularly interesting class of SIM-containing proteins are the so-called 
SUMO-targeted ubiquitin ligases (STUbLs), which represent a link between the 
SUMO and the ubiquitin system (Praefcke et al., 2012). STUbLs are specialized 
RING-type ubiquitin E3 ligases that harbor multiple SIMs and thereby are specifically 
recruited to polySUMOylated proteins. Prototypical members of this class of 
enzymes are Ris1 and the Slx5/Slx8 heterodimer in yeast (Uzunova et al., 2007) as 
well as RNF4 in vertebrates (Tatham et al., 2008). Moreover, by catalyzing substrate 
modifications with polyubiquitin chains, STUbLs regulate the proteasomal turnover of 
SUMO conjugates (Tatham et al., 2008; Uzunova et al., 2007). 
 An example for a non-proteolytic function of a STUbL is the ubiquitin E3 
ligase Rad18 in S. cerevisiae. Rad18 binds SUMOylated PCNA in a SIM-dependent 
manner and mediates the non-proteolytic monoubiquitylation of different PCNA 
subunits (Parker and Ulrich, 2012). Similarly, RNF4 appears to possess non-
proteolytic activities, which are involved in the DNA damage response in human cells 
(Yin et al., 2012). 
1.1.5 Distinctive features of the ubiquitin and SUMO systems 
Although protein modification by ubiquitin and SUMO is similar at multiple levels, 
both conjugation systems possess unique features. Characteristic for the ubiquitin 
system is its hierarchically organized and highly diversified enzymatic machinery. For 
instance, in the yeast S. cerevisiae, eleven E2s, 60-100 E3s and 20 DUBs have 
been discovered (Finley et al., 2012). By contrast, SUMOylation is controlled by a 
remarkably small number of enzymes, comprising a single E2 (Ubc9), four E3 ligases 
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(Siz1, Siz2, Mms21 and Zip3) and two SUMO-specific isopeptidases (Ulp1 and Ulp2) 
in S. cerevisiae. 
 PTMs often target individual proteins with high selectivity and enzyme 
diversification is of fundamental importance for substrate specificity in the ubiquitin 
pathway (Kerscher et al., 2006). Similar to ubiquitylation and despite the remarkable 
simplicity of its enzymatic apparatus, the SUMO system targets a plethora of cellular 
substrates as well. Thus, the question has been raised how substrate specificity in 
the SUMO system is achieved (Psakhye and Jentsch, 2012). 
 Among the mechanisms that ensure substrate specificity in the SUMO 
pathway, the targeting of SUMO E3 ligases to distinct cellular localizations and 
compartments is of particular relevance (Jentsch and Psakhye, 2013). Additionally, a 
recent study on the SUMOylation of proteins involved in homologous recombination 
revealed that the SUMO system frequently targets entire protein complexes rather 
than single substrates (protein group SUMOylation) (Psakhye and Jentsch, 2012). 
Thus, substrate selectivity can be achieved by the specific recruitment of SUMO 
enzymes to the vicinity of preassembled protein complexes. Moreover, it has been 
proposed that multiple SUMO modifications act synergistically to foster the stability of 
protein complexes by SUMO-SIM interactions. Hence, the intriguing concept of 
protein group SUMOylation also provides an explanation for the observation that 
removal of SUMO acceptor sites in single substrates often barely causes 
phenotypes. Accordingly, only the wholesale elimination of SUMOylation of an entire 
protein group has strong consequences and in case of the homologous 
recombination pathway significantly delays DNA repair (Psakhye and Jentsch, 2012). 
1.1.6 The SUMO system in the context of cellular compartments 
In contrast to other PTM pathways like phosphorylation, acetylation and 
ubiquitylation, which generally act throughout the cell, SUMOylation has emerged as 
a primarily nuclear modification (Kamitani et al., 1997). In fact, certain SUMO 
substrates require an intact nuclear localization signal (NLS) for efficient 
SUMOylation in vivo (Sternsdorf et al., 1999). Moreover, studies on an artificially 
designed reporter protein indicated that in some cases the combination of a 
ΨKX(D/E)-type consensus motif and an NLS is sufficient to trigger SUMOylation 
(Rodriguez et al., 2001). 
 The predominantly nuclear activities of the SUMO system have been further 
substantiated by several large-scale studies, which have identified hundreds of 
potential SUMO substrates in yeast and more than 1000 in human cells. The majority 
of these substrates indeed appears to be nuclear (Wohlschlegel et al., 2004) and a 
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recent evaluation of human SUMO proteomics studies has reported that in fact 
~96 % of the top 200, ~93 % of the top 500 and ~86 % of the top 1000 most-
frequently identified SUMO substrates are annotated as nuclear proteins (Hendriks 
and Vertegaal, 2016). 
 A prerequisite for the SUMOylation of substrate proteins in a given cellular 
compartment is the local presence of SUMO enzymes. Indeed, many components of 
the SUMO system predominantly reside in the nucleus (Johnson, 2004; Melchior et 
al., 2003; Seeler and Dejean, 2003) and dedicated nuclear import pathways have 
been reported for the SUMO E1 (Moutty et al., 2011) and E2 enzymes (Grunwald 
and Bono, 2011; Mingot et al., 2001). Moreover, distinct nuclear localizations have 
been described for several SUMO E3 ligases such as Pc2 (Kagey et al., 2003; 
Roscic et al., 2006), Mms21 (NSE2) (Potts and Yu, 2005; Zhao and Blobel, 2005) 
and members of the human PIAS protein family (Kotaja et al., 2002; Miyauchi et al., 
2002; Sachdev et al., 2001). Likewise, in yeast, Siz2 is a predominantly nuclear 
protein and Siz1 is enriched in the nucleus during most phases of the cell cycle 
(Makhnevych et al., 2007; Takahashi and Kikuchi, 2005). Lastly, multiple SUMO 
isopeptidases primarily localize to the nucleus in both yeast and human cells (Hickey 
et al., 2012). 
 Despite its prevalence in the nucleus, the SUMO system is not entirely 
restricted to this compartment and a number of cytosolic SUMO substrates have 
been described (Figure 3). Consistently, enzymes of the SUMO conjugation system 
have been detected in the cytosol, albeit mostly in much smaller fractions than in 
nucleus (Bossis and Melchior, 2006; Donaghue et al., 2001; Lee et al., 1998; 
Makhnevych et al., 2007; Pichler et al., 2002; Takahashi et al., 2008; Takahashi and 
Kikuchi, 2005; Zhang et al., 2002). Well-studied examples of cytosolic SUMO 
substrates are the mammalian Ran GTPase-activating protein 1 (RanGAP1) at the 
cytoplasmic face of the nuclear pore complex (NPC) and the septins located at the 
bud neck in yeast cells. Septin SUMOylation requires a cytosolic pool of the SUMO 
E3 ligase Siz1, which is exported from the nucleus by the karyopherin Kap142/Msn5 
prior to anaphase (Makhnevych et al., 2007). Notably, septins are deSUMOylated 
during cytokinesis by the SUMO protease Ulp1 (Makhnevych et al., 2007; Takahashi 
et al., 2000), demonstrating that SUMO isopeptidases exert distinct functions in the 
cytosol as well. 
 Apart from substrates with restricted localization, several soluble SUMO 
substrates have been identified in the cytosol. Examples range from yeast glycolytic 
enzymes such as Pgk1 (Psakhye and Jentsch, 2012) to intermediate filament 
proteins in C. elegans (Kaminsky et al., 2009). A particularly interesting case is the 
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mammalian proto-oncogene c-Myb, which is SUMOylated in the cytosol by the E3 
ligase TRAF7. Compartment-specific SUMOylation of c-Myb inhibits its nuclear 
import and thereby causes the cytosolic sequestration of this protein (Morita et al., 
2005). 
 Intriguingly, cytosolic SUMOylation also affects proteins at the cytosolic 
interfaces of the endoplasmic reticulum (ER), the mitochondrial outer membrane and 
the plasma membrane (Figure 3). First evidence for an implication of the SUMO 
system in the regulation of plasma membrane proteins came from studies on the 
glucose transporters GLUT1 and GLUT4 (Giorgino et al., 2000). Both GLUT1 and 
GLUT4 interact with the SUMO E2 enzyme Ubc9 via their cytosolic C-termini and it 
has been proposed that both transporters are modified by SUMO. Moreover, 
overexpression of Ubc9 severely altered the expression levels of the glucose 
transporters, leading to decreased abundance of GLUT1 and strongly increased 
abundance of GLUT4. 
 
 
 
Figure 3. SUMO substrates in the context of cellular compartments. Protein modification by SUMO 
affects a multitude of cellular substrates. The majority of SUMO substrates localizes to the nucleus, 
where SUMOylation regulates essential processes such as replication, transcription and DNA repair. 
Apart from the nucleus, SUMO targets are also found in the cytosol and the cytosolic interfaces of the 
plasma membrane, the nuclear pore complex (NPC), the endoplasmic reticulum (ER) and mitochondria 
(see main text for details). A further group of cytosolic SUMO substrates are the septin proteins in yeast, 
which assemble at the bud neck during cytokinesis. 
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 Following this initial discovery, later studies provided detailed insights into the 
SUMO regulation of plasma membrane proteins. The first SUMO substrate to be 
described was the K+ leak channel K2P1. It has been reported that K2P1 is 
SUMOylated at Lys 274, resulting in the inactivation of the channel (Rajan et al., 
2005). However, a subsequent study questioned whether K2P1 is indeed regulated 
by SUMOylation (Feliciangeli et al., 2007), indicating that this issue requires further 
clarification. Nevertheless, SUMO-mediated regulation of channel activity has been 
confirmed for other substrates, for instance the voltage-gated potassium channel 
Kv1.5 (Benson et al., 2007). Kv1.5 is SUMOylated at two lysine residues located 
within cytosolic domains of the channel and the modification is involved in channel 
inactivation. Additional SUMO substrates at the plasma membrane include 
metabotropic and ionotropic glutamate receptors (Martin et al., 2007a; Tang et al., 
2005; Wilkinson et al., 2008). Notably, it has been reported that SUMOylation of the 
ionotropic kainate receptor subunit GluR6 is crucial for the endocytosis of the 
receptor, thereby providing a link between the SUMO system and receptor-mediated 
endocytosis (Martin et al., 2007a). 
 SUMOylation also targets proteins at the cytosolic interface of cellular 
organelles. Such substrates include the ER-associated protein-tyrosine 
phosphatase-1B (Dadke et al., 2007) and the dynamin-related GTPase Drp1, which 
translocates from the cytosol to the outer mitochondrial membrane to regulate 
mitochondrial fission (Harder et al., 2004). Notably, Drp1 SUMOylation is dependent 
on the mitochondria-anchored protein ligase (MAPL), the first SUMO E3 ligase that 
has been reported to be associated with mitochondria (Braschi et al., 2009). 
Moreover, SUMOylation of Drp1 is negatively regulated by SENP5 (Zunino et al., 
2007), thus highlighting a further example for the function of a SUMO-specific 
isopeptidase in the cytosol. 
 Taken together, current knowledge about the SUMO system indicates that 
SUMO modification targets diverse substrates, which are accessible to nuclear and 
cytosolic SUMO enzymes. However, SUMOylation appears to be absent within 
particular organelles such as the ER and mitochondria and the question whether 
proteins transported into these organelles are SUMO substrates in vivo has not been 
elucidated so far. 
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1.2 Biogenesis of mitochondrial proteins 
Mitochondria are double-membrane organelles involved in multiple cellular pathways. 
Besides their prominent role in ATP production, mitochondria are crucial for the 
biosynthesis of lipids, amino acids and heme and at least one mitochondrial function, 
the formation of iron-sulfur clusters, is strictly essential for cell viability in all 
organisms (Lill and Muhlenhoff, 2008; Neupert and Herrmann, 2007). Moreover, in 
vertebrates, mitochondria have been implicated in the regulation of innate and 
adaptive immunity and are of fundamental importance for the execution of apoptosis 
(Wang and Youle, 2009; Weinberg et al., 2015). 
 Proteomic studies have suggested that mitochondria contain about 1000 
proteins in yeast and 1500 proteins in human cells (Pagliarini et al., 2008; Perocchi 
et al., 2006; Sickmann et al., 2003). However, only a small number of these proteins 
are encoded in the mitochondrial genome and translated by mitochondrial 
ribosomes. The vast majority of mitochondrial proteins are encoded in the nuclear 
genome and synthesized as precursor proteins on cytosolic ribosomes. Subsequent 
sorting of these proteins into their functional environment often involves proteolytic 
processing, equipment with cofactors and assembly into larger functional protein 
complexes. Moreover, since mitochondria are made up of two membranes, proteins 
can be targeted to one out of four submitochondrial destinations: the outer 
membrane (OM), the intermembrane space (IMS), the inner membrane (IM) or the 
matrix. 
1.2.1 Mitochondrial targeting signals 
Protein import into mitochondria requires targeting sequences that harbor the 
information to which membrane or subcompartment a particular protein is sorted. 
Prototypical mitochondrial targeting signals are cleavable presequences, which are 
characteristically located at the N-termini of precursor proteins (Neupert, 1997; 
Neupert and Herrmann, 2007). They usually direct proteins to the mitochondrial 
matrix in an N to C direction and therefore are referred to as matrix targeting signals 
(MTS). MTSs typically comprise 10-80 amino acid residues and form amphipathic α-
helices with one hydrophobic and one positively charged surface. After import into 
the mitochondrial matrix, most N-terminal targeting signals are proteolytically 
removed by the dimeric mitochondrial processing peptidase (MPP). Notably, the N-
terminal localization of the MTS appears to be critical for its function and 
transplantation of a MTS to internal regions of proteins does not facilitate 
mitochondrial targeting. However, artificial fusion of an MTS to the C-terminus of a 
protein can mediate mitochondrial targeting but leads to a C- to N-terminal 
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translocation direction (Folsch et al., 1998). Remarkably, it has been reported that in 
one case, the yeast DNA helicase Hmi1, the MTS is naturally located at the C-
terminus of the protein (Lee et al., 1999). 
 In addition to an MTS, a number of mitochondrial IM and IMS proteins contain 
further hydrophobic sorting signals C-terminal to the MTS, which are often followed 
by a cluster of charged amino acid residues (Rojo et al., 1998). For IM proteins, 
these hydrophobic sorting signals serve as transmembrane domains, which arrest 
translocation within the inner mitochondrial membrane and facilitate lateral sorting 
into the lipid phase (stop-transfer pathway) (Gartner et al., 1995; Glaser et al., 1990; 
Glick et al., 1992; Miller and Cumsky, 1993). Moreover, various IMS proteins contain 
so-called bipartite presequences, which are proteolytically processed after 
embedment into the inner membrane. Thereby the mature proteins are released into 
the intermembrane space (Gakh et al., 2002; Glick et al., 1992). 
 Besides the classical N-terminal presequences, a variety of less-defined 
internal mitochondrial targeting and sorting signals have been described. Such 
targeting signals are found in diverse mitochondrial proteins, including all proteins of 
the outer mitochondrial membrane, many intermembrane space and inner membrane 
proteins as well as a small number of matrix proteins (Chacinska et al., 2009). 
1.2.2 Mitochondrial protein sorting 
The majority of mitochondrial proteins are imported via the translocase of the outer 
membrane (TOM complex). Central component of this complex is the general import 
pore formed by the β-barrel protein Tom40 (Ahting et al., 2001; Model et al., 2008). 
Additional subunits are the receptor proteins Tom20, Tom70 and Tom22. Whereas 
Tom20 serves as major recognition site for preproteins with N-terminal targeting 
signals (Abe et al., 2000; Ramage et al., 1993; Saitoh et al., 2007; Sollner et al., 
1989), Tom70 mainly binds proteins with multiple internal targeting signals such as 
carrier proteins (Chan et al., 2006; Sollner et al., 1990; Wu and Sha, 2006). A central 
receptor subunit, Tom22, promotes the general integrity of the TOM complex and 
transfers incoming proteins from Tom20 and Tom70 to the translocation pore (van 
Wilpe et al., 1999). 
 After passage through the TOM complex, mitochondrial proteins can follow 
different routes to reach their submitochondrial destination (Figure 4). The 
embedment of proteins into the outer mitochondrial membrane often requires the 
sorting and assembly machinery (SAM), which mediates the maturation of β-barrel 
(Paschen et al., 2003; Wiedemann et al., 2003) and a subset of α-helical proteins 
(Stojanovski et al., 2007). 
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Figure 4. Mitochondrial protein sorting pathways. The vast majority of mitochondrial proteins are 
encoded in the nucleus and synthesized as precursor proteins on cytosolic ribosomes. In the cytosol, 
mitochondrial precursor proteins associate with molecular chaperones such as heat shock proteins 
(HSP), which maintain their import-competence and facilitate import into the organelle. Many precursor 
proteins harbor cleavable N-terminal targeting sequences (presequences), however, proteins with 
internal targeting signals have also been described. Almost all mitochondrial proteins are imported via a 
general entry gate formed by the translocase of the outer membrane (TOM complex). Specific 
components of the TOM complex also serve as receptors that bind mitochondrial preproteins at the 
cytosolic interface of the outer membrane. Following entry through the TOM complex, mitochondrial 
proteins follow different sorting pathways to one of the mitochondrial membranes or subcompartments. 
These include the outer mitochondrial membrane, the intermembrane space, the inner mitochondrial 
membrane and the mitochondrial matrix. Roughly 1 % of the mitochondrial proteome is encoded by the 
endogenous genome and synthesized as mitochondrial translation products. Depicted are various 
protein complexes involved in mitochondrial protein sorting: MIA, mitochondrial intermembrane space 
assembly; OXA, insertase/export machinery of the inner membrane; SAM, sorting and assembly 
machinery; TIM9/10, small TIM proteins that function as intermembrane space chaperones; TIM22 
complex, carrier translocase of the inner membrane; TIM23 complex, presequence translocase of the 
inner membrane; TIM44, membrane anchor for mitochondrial HSP70 (mtHSP70); TIM44 and mtHSP70 
are components of the presequence translocase-associated motor (PAM) complex. 
 
 Proteins solely carrying N-terminal signal sequences are usually transported 
into the mitochondrial matrix. This sorting pathway involves the translocase of the 
inner membrane (TIM23 complex) and the presequence translocase-associated 
motor (PAM) complex (Chacinska et al., 2009; Neupert and Herrmann, 2007). In the 
matrix, N-terminal targeting sequences are typically removed by the mitochondrial 
processing peptidase (MPP). Moreover, emerging proteins are bound by 
mitochondrial HSP70 (mtHSP70), which is recruited to the inner mitochondrial 
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membrane by the protein Tim44. Both proteins are components of the PAM complex, 
which utilizes the energy of ATP to stimulate protein translocation into the matrix. 
 In addition to its role in the biogenesis of matrix proteins, the TIM23 complex 
is involved in the import of IM proteins via the stop-transfer pathway and also 
mediates the sorting of IMS proteins that contain bipartite presequences (see section 
1.2.1). A special group of IMS proteins is sorted via the mitochondrial intermembrane 
space assembly (MIA) machinery. Central component of this pathway is the receptor 
protein Mia40 (Chacinska et al., 2004; Mesecke et al., 2005; Naoe et al., 2004), 
which binds cysteine-containing substrates emerging from the TOM complex via a 
hydrophobic interface and its redox-active cysteine-proline-cysteine (CPC) motif 
(Grumbt et al., 2007; Milenkovic et al., 2007; Milenkovic et al., 2009). Subsequently, 
Mia40 catalyzes the formation of disulfide bridges within precursor proteins and 
releases the oxidized and mature proteins into the intermembrane space (Muller et 
al., 2008; Terziyska et al., 2009). 
 Besides the TIM23-dependent pathway, an alternative route to the inner 
mitochondrial membrane is the so-called carrier pathway (Chacinska et al., 2009). 
Metabolite carrier proteins contain several internal targeting signals and in most 
cases are translated on cytosolic ribosomes. In the cytosol, carrier precursors are 
usually bound by molecular chaperones that protect them from aggregation and 
guide them to the Tom70 receptor at the outer mitochondrial membrane (see section 
1.2.4). After translocation through the TOM complex, carrier proteins are recognized 
by a chaperone-like hexameric complex composed of the small TIM proteins Tim9 
and Tim10 (Curran et al., 2002; Vasiljev et al., 2004). These factors facilitate the 
further transfer to the TOM22 complex, which eventually mediates the assembly of 
carrier proteins in the inner mitochondrial membrane. 
 Notably, the inner mitochondrial membrane also contains proteins encoded in 
the mitochondrial genome and synthesized on mitochondrial ribosomes. These 
proteins function as subunits of mitochondrial respiratory chain complexes and reach 
their mature state via the insertase/export machinery of the inner membrane (OXA 
complex). For some substrates, the OXA complex also participates in the so-called 
conservative sorting pathway (Hell et al., 1997; Hell et al., 1998). This pathway 
directs nucleus-encoded proteins from the cytosol into the matrix and from there into 
the inner membrane (Neupert and Herrmann, 2007). 
1.2.3 Cotranslational and posttranslational protein import 
A multitude of studies indicate that most mitochondrial proteins are translated on 
cytosolic ribosomes and posttranslationally imported into the organelle (Neupert, 
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1997; Neupert and Herrmann, 2007). First observations of posttranslational protein 
import into mitochondria were made by in vivo pulse and pulse-chase experiments 
using intact cells. It has been reported that fully translated precursors of 
mitochondrial proteins appear first in the cytosol and subsequently are converted into 
mature mitochondrial forms (Hallermayer et al., 1977). Importantly, the import 
kinetics vary for different precursor proteins and protein translocation into 
mitochondria continues even after the inhibition of translation by cycloheximide 
(Hallermayer et al., 1977). This strongly suggests that protein translocation into 
mitochondria is indeed not coupled to translation. 
 The findings that mitochondrial protein import can occur efficiently in a 
posttranslational manner in vivo were further substantiated by in vitro studies 
analyzing the import of proteins into isolated mitochondria. Using cell-free translation 
systems, protein synthesis and translocation into mitochondria can be entirely 
separated (Hartl et al., 1986). When precursor proteins are first translated and 
released into the postribosomal supernatant, mitochondrial import can be observed 
after the addition of isolated mitochondria to the supernatant. 
 Despite various observations that support a model of predominantly 
posttranslational protein import into mitochondria, cotranslational and 
posttranslational sorting modes are not mutually exclusive and appear to occur in 
parallel. In fact, it has been reported that cytoplasmic 80S ribosomes are associated 
with mitochondria (Kellems et al., 1974, 1975; Kellems and Butow, 1972, 1974) and 
that mitochondrial proteins are translated from both mitochondria-bound as well as 
free cytosolic polysomes (Suissa and Schatz, 1982). Moreover, distinct mRNAs 
encoding mitochondrial proteins appear to be selectively translated at the surface of 
the outer mitochondrial membrane. Targeting of mRNAs to mitochondria is mediated 
by diverse mechanisms (Fox, 2012) and for some proteins increases import 
efficiency (Margeot et al., 2002). 
 In general, since most mitochondrial proteins contain N-terminal targeting 
signals, it is conceivable that import initiates as soon as the N-terminus of a nascent 
polypeptide binds the import receptors at the outer mitochondrial membrane. 
Consistently, it has been reported that the enrichment of certain mRNAs at the 
mitochondrial surface requires translation and is dependent on the presequence-
binding receptor Tom20 (Eliyahu et al., 2010). 
 In summary, compelling evidence indicates that mitochondrial protein import 
is not generally coupled to translation and occurs posttranslationally as well as 
cotranslationally in vivo. However, in any case, it appears to be a fast and efficient 
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process and cytosolic pools of probably most mitochondrial precursor proteins are 
barely detectable in vivo (Ades and Butow, 1980b). 
1.2.4 A role for cytosolic factors in mitochondrial protein import 
Protein transport into mitochondria requires the translocation of polypeptides through 
narrow import pores (Ahting et al., 2001; Schwartz and Matouschek, 1999; Truscott 
et al., 2001). Thus, preproteins adopt a largely unfolded state during import and 
usually traverse the mitochondrial import channels as linear chains (Rassow et al., 
1990; Schwartz et al., 1999). In fact, it has been reported that the import of 
mitochondrial preproteins is impaired when their three-dimensional structure is 
stabilized (Eilers and Schatz, 1986; Rassow et al., 1989; Wienhues et al., 1991). 
Empowered by an electrochemical proton gradient and an ATP-driven import motor, 
mitochondria can actively unfold preproteins (Matouschek et al., 2000). However, to 
facilitate import, cytosolic mitochondrial precursor proteins are thought to generally 
adopt a more loosely folded state than their mature forms (Neupert, 1997). 
Remarkably, this might be partially attributed to the presence of N-terminal 
presequences, which can interfere with the folding of precursor proteins prior to 
import (Hoogenraad et al., 2002; Lain et al., 1995). Nevertheless, the import 
competence of mitochondrial preproteins is in many cases maintained by cytosolic 
factors, which stabilize unfolded conformations and prevent their aggregation in the 
cytosol. The existence of such factors was in fact suggested early on by the 
observation that rabbit reticulocyte lysates (Argan et al., 1983; Miura et al., 1983; 
Ohta and Schatz, 1984; Pfanner and Neupert, 1987; Randall and Shore, 1989; 
Sheffield et al., 1986) as well as yeast cytosolic extracts (Murakami et al., 1988; Ohta 
and Schatz, 1984) stimulate the uptake of polypeptides into isolated mitochondria 
in vitro. 
1.2.4.1 HSP70 and HSP90 
First evidence for a function of molecular chaperones in mitochondrial protein import 
came from studies on the SSA subfamily of HSP70s in yeast. Conditional depletion 
of this family of chaperones results in the accumulation of mitochondrial precursor 
proteins in vivo (Deshaies et al., 1988). In agreement with these findings, it has been 
reported that SSA family HSP70s also stimulate protein translocation into isolated 
mitochondria in vitro (Murakami et al., 1988). 
 Similar to yeast cells, cytosolic chaperones are also involved in mitochondrial 
protein import in mammals. In vitro import assays have revealed that the HSP70 
isoform HSC70 delays the folding and inhibits the aggregation of purified 
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mitochondrial precursor proteins (Sheffield et al., 1990). Moreover, HSC70 stimulates 
the translocation of proteins into isolated rat liver mitochondria (Terada et al., 1995). 
 The activity of HSP70 proteins is regulated by a variety of co-chaperones that 
stimulate the ATPase activity of HSP70 or function as nucleotide exchange factors 
(NEFs). To date, no evidence for an involvement of NEFs in mitochondrial protein 
import has been provided. However, the yeast HSP40 protein Ydj1 (Atencio and 
Yaffe, 1992; Caplan et al., 1992) as well as its orthologs Dj2 and Dj3 in human cells 
(Kanazawa et al., 1997; Terada and Mori, 2000) have been linked to the biogenesis 
of mitochondrial proteins and are required for the import of at least a subset of 
proteins in cell-free assays. 
 Besides HSP70, mammalian cells employ the HSP90 chaperone system to 
stimulate protein import into mitochondria. Remarkably, HSP70 and HSP90 
chaperones not only maintain the import competence of precursor proteins but also 
actively deliver preproteins to the Tom70 import receptor at the outer mitochondrial 
membrane (Young et al., 2003). 
1.2.4.2 Mitochondrial import stimulation factor (MSF) 
The mitochondrial import machinery of mammalian cells appears generally more 
complex than the corresponding system in yeast. Consistently, further cytosolic 
factors with active targeting functions have been identified. Best-characterized 
among these proteins is the mitochondrial import stimulation factor (MSF), which was 
purified from rat liver cytosol using a presequence peptide coupled to an affinity 
matrix (Hachiya et al., 1993). MSF belongs to the family of 14-3-3 proteins (Alam et 
al., 1994) and facilitates the import of multiple preproteins with different types of 
targeting signals (Hachiya et al., 1993). Thus, it has been suggested that MSF might 
generally bind mitochondrial precursor proteins independently of N-terminal 
presequences (Hachiya et al., 1993). 
 Import stimulation by MSF seems to be based on two different activities. First, 
MSF binds mitochondrial preproteins and maintains their import competence in a 
chaperone-like manner. Additionally, the chaperone-like functions of MSF comprise 
an ATP-dependent disaggregation activity, which enables it to resolubilize 
aggregated mitochondrial precursor proteins (Hachiya et al., 1993; Hachiya et al., 
1994; Komiya et al., 1994). Second, MSF fulfills an active targeting function and 
guides proteins to the mitochondrial surface. MSF-dependent mitochondrial protein 
import seems to act in parallel to HSP70-dependent pathways and delivers client 
proteins to the mitochondrial import receptor Tom70. At the TOM complex, MSF is 
released in an ATP-dependent manner and the preproteins are transferred to the 
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import receptors Tom20 and Tom22. Subsequently, translocation through the outer 
mitochondrial membrane is initiated (Hachiya et al., 1995; Komiya et al., 1997; 
Komiya et al., 1996). 
1.2.4.3 Targeting factor and presequence binding factor (PBF) 
Apart from MSF, a number of cytosolic factors specifically implicated in protein 
transport into mitochondria have been identified. One example is a 28 kDa protein 
termed targeting factor, which stimulates mitochondrial import of several preproteins 
in vitro. Interestingly, targeting factor also increases the amount of preproteins bound 
to the mitochondrial outer membrane, suggesting that it actively delivers polypeptides 
to the TOM complex (Ono and Tuboi, 1988, 1990a, b). 
 A further import-stimulating protein termed presequence binding factor (PBF) 
has been isolated by its binding specificity towards the precursor of rat ornithine 
carbamoyltransferase (Murakami and Mori, 1990). PBF has been shown to maintain 
the import competence of certain mitochondrial precursor proteins in cell-free import 
assays and to stimulate the import of several polypeptides into isolated mitochondria 
(Murakami and Mori, 1990; Murakami et al., 1992). 
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1.3 Cellular mechanisms of protein quality control 
Accurate folding into a distinct three-dimensional structure is a crucial prerequisite for 
the functions of cellular proteins. However, proteins are structurally dynamic 
macromolecules and misfolded proteins can arise from different sources such as 
errors during folding of de novo synthesized polypeptides or stress-induced unfolding 
of native proteins. In many cases, non-native proteins expose stretches of 
hydrophobic amino acids, which are normally buried inside the structure of an 
appropriately folded protein. Therefore, protein misfolding not only interferes with the 
functions of proteins but also causes the formation of insoluble and potentially 
cytotoxic aggregates. Consequently, cells have evolved a sophisticated network of 
surveillance mechanisms that monitor accurate protein folding and maintain the 
integrity of the proteome (proteostasis). 
1.3.1 Recognition of non-native proteins by molecular chaperones 
Central component of cellular protein quality control is a system of molecular 
chaperones, which recognize and bind non-native proteins. Many molecular 
chaperones were originally discovered as heat shock-induced proteins and the major 
families of these heat shock proteins (HSPs) are classified according to their 
molecular weight (HSP100, HSP90, HSP70, HSP60, HSP40 and small HSPs) (Hartl 
et al., 2011). Each class of molecular chaperones utilizes a distinct mode of client 
binding and usually possesses a specific set of substrate proteins. However, in many 
cases, non-native protein conformations are recognized by the interaction of HSPs 
with hydrophobic peptide segments, which are exposed by unfolded or misfolded 
proteins. 
 HSP70 proteins are part of a major ATP-dependent chaperone system that 
functions ubiquitously throughout the cell and interacts with a multitude of substrate 
proteins. HSP70 proteins are involved in a wide range of cellular processes including 
de novo folding of nascent polypeptides, refolding of misfolded or aggregated 
proteins, targeting of mitochondrial (see section 1.2.4) and secretory proteins and 
regulation of protein activity (Mayer and Bukau, 2005). On the molecular level, the 
functions of HSP70s rely on three different but related activities: promoting the 
solubility of unfolded proteins, assisting the folding process into the native state and 
resolubilization of aggregated protein species. All of these activities appear to be 
based on the property of HSP70 to bind short linear peptide segments, which are 
enriched in hydrophobic and basic amino acids (Rudiger et al., 1997; Zhu et al., 
1996). Reversible binding to these hydrophobic stretches accounts for the solubility-
promoting activity of HSP70 and might also provide time for the folding of substrate 
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proteins to proceed. Moreover, HSP70 has been implicated in active disaggregation 
processes (Diamant et al., 2000; Nillegoda et al., 2015; Rampelt et al., 2012), where 
it often cooperates with disaggregases of the HSP100 family (Glover and Lindquist, 
1998; Goloubinoff et al., 1999). 
 Substrate interactions of HSP70s are regulated by repeated cycles of ATP 
binding, hydrolysis and ADP release during which HSP70 switches between a high-
affinity ATP-bound state and a low-affinity ADP-bound state. Factors that stimulate 
the ATPase activity of HSP70 belong to the diverse class of J domain-containing co-
chaperones (HSP40s). HSP40 proteins also interact directly with substrate proteins 
and recruit HSP70 to binding sites in close proximity, thereby contributing to the 
substrate specificity and functional diversity of the HSP70 chaperone system 
(Kampinga and Craig, 2010). Besides HSP40, the ATPase cycle of HSP70 is 
regulated by nucleotide exchange factors (NEFs) (Bracher and Verghese, 2015a, b). 
NEFs stimulate the release of ADP + Pi from HSP70 and allow a new round of ATP 
binding, which in turn triggers substrate release. 
In addition to the HSP70 system, HSP90 and HSP60 represent further 
families of ATP-dependent chaperones, which function in protein folding and protein 
quality control (Kim et al., 2013; Taipale et al., 2010). Moreover, a number of ATP-
independent small heat shock proteins (sHSPs) possess chaperone-like activities 
and participate in the HSP-dependent protective systems, which counteract the 
aggregation of cellular proteins (Garrido et al., 2012). 
1.3.2 Functions of the ubiquitin-proteasome system in protein quality control 
The maintenance of proteostasis by cellular protein quality control systems is 
critically balanced by the triage decision whether non-native proteins are refolded or 
degraded. Remarkably, for the clearance of proteins, which are refractory to 
refolding, cellular chaperone systems closely collaborate with the ubiquitin-
proteasome system (UPS). This functional interconnection of HSPs, ubiquitin E3 
ligases and the 26S proteasome ultimately mediates the degradation of the majority 
of soluble misfolded proteins in a cell (Figure 5). 
 A prototypical example for the collaboration of chaperones with the UPS is 
the mammalian ubiquitin E3 ligase carboxy terminus of HSC70-interacting protein 
(CHIP). CHIP interacts with HSP70 and HSP90 via its tetratricopeptide domain and 
catalyzes the ubiquitylation of HSP70 and HSP90 substrates via its U-box domain 
(Ballinger et al., 1999; Connell et al., 2001; Demand et al., 2001; Jiang et al., 2001; 
Murata et al., 2001). CHIP thereby mediates the chaperone-dependent proteasomal 
degradation of various proteins including the glucocorticoid receptor (Connell et al., 
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2001), the receptor tyrosine kinase ErbB2 (Xu et al., 2002) and generally 
aggregation-prone chaperone substrates (Meacham et al., 2001; Petrucelli et al., 
2004). 
 Interestingly, while CHIP appears to be a central factor of protein quality 
control in higher eukaryotes, links between chaperones and UPS-mediated protein 
degradation have also been identified in organisms, which lack a functional homolog 
of CHIP. For instance, in yeast, cytosolic misfolded proteins are degraded by a 
unique pathway that involves the parallel activities of the cytosolic ubiquitin E3 ligase 
Ubr1 and the nuclear E3 ligase San1 (Eisele and Wolf, 2008; Heck et al., 2010; 
Nillegoda et al., 2010; Prasad et al., 2010). It has been reported that substrates of 
this pathway are degraded in an HSP70-dependent manner (Park et al., 2007) and 
Ubr1-mediated ubiquitylation is indeed stimulated by HSP70 (Heck et al., 2010; 
Nillegoda et al., 2010). 
 
 
 
Figure 5. Pathways mediating the degradation of misfolded proteins by the ubiquitin-proteasome 
system. Various quality control components mediate the recognition, ubiquitylation and degradation of 
misfolded proteins. Particularly, molecular chaperones of the HSP70 and HSP40 families are involved in 
the recognition of non-native protein conformers. In concert with molecular chaperones, dedicated 
ubiquitin E3 ligases catalyze the ubiquitin (Ub) modification of misfolded proteins. Examples for ubiquitin 
E3 ligases involved in protein quality control are depicted (Ubr1/2, San1, Rsp5, Hul5 and Doa10 in 
S. cerevisiae; CHIP in vertebrates). Nuclear import of misfolded proteins for San1-mediated degradation 
requires specific HSP40 proteins (Sis1 in S. cerevisiae). The degradation of ubiquitylated substrates is 
ultimately mediated by the 26S proteasome. 
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Moreover, delivery of cytosolic substrates to the nuclear ubiquitin E3 ligase San1 
requires HSP70 (Prasad et al., 2010) and the HSP40 protein Sis1 (Park et al., 2013), 
suggesting a dual role of chaperone factors in the degradation of misfolded cytosolic 
proteins. Remarkably, the transport of non-native proteins into the nucleus for 
degradation appears to be conserved among species and requires the Sis1 homolog 
DnaJB1 in mammalian cells (Park et al., 2013). 
 Protein misfolding can occur spontaneously in cells but is strongly induced by 
stress conditions such as heat shock. Under these circumstances, a variety of 
proteins are targeted for degradation by the proteasome. In yeast, heat shock-
induced ubiquitylation exquisitely involves two ubiquitin E3 ligases, Hul5 (Fang et al., 
2011) and Rsp5 (Nedd4 in humans) (Fang et al., 2014). Notably, heat shock-induced 
Rsp5-dependent ubiquitylation also requires the HSP40 protein Ydj1 (Fang et al., 
2014), thus providing a further link between chaperones and the UPS in protein 
quality control. 
 Additional components of the ubiquitin system that have been implicated in 
protein quality control in yeast are the Ubr1 homolog Ubr2 (Nillegoda et al., 2010) 
and the ER-bound E3 ligase Doa10, which mediates the clearance of a number of 
soluble cytosolic and nuclear proteins (Metzger et al., 2008; Ravid et al., 2006; 
Swanson et al., 2001). 
1.3.3 A role for SUMO in protein quality control 
Despite the discovery of hundreds of potential SUMO substrates in yeast and 
mammalian cells, the molecular consequences and functions of SUMOylation have 
been revealed for only a subset of SUMO substrates. However, SUMO has been 
widely implicated as a “stress protein”. Similar to ubiquitylation, SUMOylation is 
strongly induced by diverse types of stress (Saitoh and Hinchey, 2000; Zhou et al., 
2004), particularly by those that cause widespread protein misfolding such as heat 
shock (HS) (Golebiowski et al., 2009; Hendriks et al., 2014; Seifert et al., 2015) or 
proteasome inhibition (Castoralova et al., 2012; Hendriks et al., 2014; Tatham et al., 
2011). Remarkably, although the exact function of HS-induced SUMOylation is still a 
matter of debate (Liebelt and Vertegaal, 2016; Niskanen et al., 2015; Seifert et al., 
2015), it has been suggested that SUMO might exhibit chaperone-like activities that 
modulate the homeostasis of protein complexes at chromatin (Seifert et al., 2015). 
 Intriguing links between the SUMO system and proteostasis have also been 
revealed by the observation that SUMOylation targets multiple aggregation-prone 
proteins involved in neurodegenerative diseases (Krumova and Weishaupt, 2013; 
Liebelt and Vertegaal, 2016). It has been reported that SUMOylation modulates the 
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aggregation and stability of several disease-associated polyQ proteins including 
mutant Huntingtin (O'Rourke et al., 2013; Steffan et al., 2004), Ataxin-1 (Guo et al., 
2014), Ataxin-7 (Janer et al., 2010) and the androgen receptor (Mukherjee et al., 
2009). Moreover, SUMO has been shown to modify proteins such as Amyloid-β (Li et 
al., 2003; Zhang and Sarge, 2008) and α-Synuclein (Abeywardana and Pratt, 2015; 
Krumova et al., 2011), which are involved in Alzheimer’s and Parkinson’s disease. 
Remarkably, in many cases SUMOylation appears to increase the solubility of 
aggregation-prone proteins, thus reducing the extent of aggregate formation 
(Abeywardana and Pratt, 2015; Guo et al., 2014; Janer et al., 2010; Krumova et al., 
2011; Mukherjee et al., 2009; Steffan et al., 2004; Zhang and Sarge, 2008). It has 
therefore been proposed that SUMO might function as a “protein solubility enhancer” 
(Krumova and Weishaupt, 2013). Additionally, it has been reported that SUMOylation 
promotes the clearance of multiple aggregation-prone substrates by the ubiquitin-
proteasome system (Guo et al., 2014), indicating a functional cooperation of the 
SUMO and ubiquitin systems in protein quality control. 
 Taken together, SUMOylation appears to play a widespread role in the 
maintenance of proteostasis and might be an integral part of the cellular stress 
response interconnected to other protein quality control systems. However, the 
molecular mechanisms responsible for the functions of SUMO as a chaperone-like 
factor remain largely undefined. 
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2 AIM OF THIS STUDY 
Since its discovery in the late 1990s (Mahajan et al., 1997; Matunis et al., 1996), 
substrates of the small ubiquitin-like modifier (SUMO) have been subject of extensive 
research. It has become evident that protein modification by SUMO affects a 
substantial part of the proteome and a multitude of nuclear and cytosolic proteins 
have been identified as SUMO substrates. However, current knowledge about the 
SUMO system strongly indicates that organellar proteins, for instance proteins 
residing inside mitochondria, are hidden from SUMO enzymes upon import (Flotho 
and Melchior, 2013). Accordingly, although a small number of mitochondrial proteins 
have been suggested as potential SUMO substrates in large-scale studies (Denison 
et al., 2005; Hannich et al., 2005; Panse et al., 2004; Wohlschlegel et al., 2004; 
Wykoff and O'Shea, 2005; Zhou et al., 2004), the question whether protein 
SUMOylation targets substrates prior to import into mitochondria has not been 
elucidated so far. 
 At the onset of this study, our laboratory had established a sensitive, mass 
spectrometry-based approach to study SUMOylated proteins in yeast (Psakhye and 
Jentsch, 2012, 2016). This experimental approach identified several potential SUMO 
substrates that were annotated as mitochondrial proteins. Struck by this remarkable 
finding, mitochondria-targeted proteins seemed to be an exceptionally fascinating 
group of novel SUMO substrates to study. Thus, the first objective of this study was 
to elucidate whether these proteins are indeed modified by SUMO in vivo. To this 
end, the SUMOylation of individual candidate proteins was analyzed in direct assays, 
thereby additionally allowing the identification of SUMO attachment sites and to study 
the involvement of SUMO E3 ligases. Based on this initial biochemical analysis, a 
second major aim of this study was to investigate the SUMOylation of mitochondria-
targeted proteins in terms of regulation and function. 
 In the context of proteins transported into an organelle, it seemed particularly 
interesting to evaluate whether their SUMOylation was dependent on import. To this 
end, import-deficient mutant variants of mitochondria-targeted proteins were 
generated and subsequently analyzed in SUMOylation assays. A further objective 
was to screen for conditions and yeast mutants in which the SUMOylation of 
mitochondria-targeted substrates is increased. This analysis aimed to identify factors, 
which regulate the modification and to eventually reveal the molecular functions of 
mitochondria-targeted protein SUMOylation. 
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3 RESULTS 
3.1 Discovery of mitochondria-targeted proteins as SUMO substrates 
Systematic analyses of SUMO substrates have established an involvement of 
SUMOylation in multiple nuclear and cytosolic pathways (Geiss-Friedlander and 
Melchior, 2007). Notably, SUMOylation might also be involved in mitochondrial 
organization in yeast (Makhnevych et al., 2009) and has been implicated in the 
regulation of mitochondrial fission in mammalian cells (Braschi et al., 2009; Harder et 
al., 2004). However, convincing evidence for SUMOylation within inner mitochondrial 
compartments has not been provided to date and the question whether SUMOylation 
targets proteins “en route” to mitochondria has not been investigated so far. 
3.1.1 A subset of mitochondrial matrix proteins are modified by SUMO in vivo 
To gain deeper insights into the SUMO-modified proteome in yeast, our laboratory 
established a SILAC-based proteomics approach, which involves the purification of 
HisSUMO conjugates from yeast cells followed by mass spectrometric (MS) analysis 
(Psakhye and Jentsch, 2012, 2016) (Figure 6A). This method relies on the usage of 
an N-terminal heptahistidine tag, which is compatible with the Ni-NTA-based 
purification of HisSUMO-modified proteins under fully denaturing conditions. Thus 
transient SUMO modifications are preserved and the co-purification of interacting 
proteins is strongly reduced. 
 Intriguingly, among a number of more than 1000 potential SUMO substrates 
(Ivan Psakhye, Fabian den Brave and Stefan Jentsch; unpublished data), this 
approach revealed a set of 86 proteins that were annotated as proteins of inner 
mitochondrial subcompartments (Figure 6B). This group of potential SUMO 
substrates included a small number of intermembrane space proteins, whereas 
proteins of the inner mitochondrial membrane and the mitochondrial matrix were 
overrepresented. Importantly, only a minor fraction (less than 10 %) of potential 
SUMO substrates were annotated as proteins with dual localization (mitochondrial 
and cytosolic), suggesting the intriguing possibility that proteins targeted exclusively 
to mitochondria are indeed SUMOylated in vivo. 
 To confirm the SUMOylation of individual proteins in direct assays, several 
candidate proteins were fused to C-terminal 3HA epitopes and expressed from their 
endogenous and the ADH1 promoter, respectively. Notably, the HA epitope tag was 
selected because it lacks lysine residues and therefore avoids the introduction of 
potential SUMO acceptor sites into a corresponding fusion protein. 
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Figure 6. A mass spectrometry-based approach identifies mitochondria-targeted proteins as 
potential SUMO substrates. (A) Schematic representation of the experimental setup used to identify 
novel SUMO conjugates in the yeast S. cerevisiae. Yeast cells expressing N-terminally His-tagged 
SUMO from the ADH1 promoter were employed to purify HisSUMO conjugates by denaturing Ni-NTA 
pull-downs. The enriched SUMO substrates were then analyzed by tryptic digestion and liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). (B) Localization and relative 
submitochondrial distribution of 86 mitochondrial proteins identified as potential SUMO substrates. 
Abbreviations indicate dual localization (dual loc.), mitochondrial intermembrane space (IMS) and 
mitochondrial inner membrane (IM). 
 
 To subsequently detect SUMOylated species of HA-tagged candidate 
proteins, SUMO conjugates were isolated from yeast cells co-expressing HisSUMO 
from the ADH1 promoter (Figure 7A). As controls, wild type yeast and cells solely 
expressing HisSUMO or the HA-tagged candidate protein were included to ensure 
specificity of the approach. Moreover, to control for pull-down efficiency in these 
assays, the SUMOylation of endogenous 3-phosphoglycerate kinase (Pgk1) was 
analyzed. 
 Strikingly, western blot analysis of the enriched SUMO conjugates confirmed 
several substrates identified by MS analysis and demonstrated that a subset of 
structurally and functionally distinct mitochondrial matrix proteins are indeed modified 
by SUMO in vivo. These proteins include Ilv6 (Figure 7B), the regulatory subunit of 
acetolactate synthase involved in branched-chain amino acid biosynthesis (Cullin et 
al., 1996; Pang and Duggleby, 1999), Adh3 (Figure 7C), a mitochondrial alcohol 
dehydrogenase isoform (Lutstorf and Megnet, 1968; Sugar et al., 1970) and Mrpl23 
(Figure 7D), a mitochondrial ribosomal protein (Kitakawa et al., 1997). Moreover, all 
confirmed substrates are nuclear-encoded proteins and contain N-terminal MTSs, 
which enable their import into the mitochondrial matrix. 
 SUMOylation of each of these substrates gave rise to a single slower-
migrating protein form, which could be specifically detected in samples from cells 
expressing the respective HA-tagged protein in combination with HisSUMO (Figure 
7B-D). The apparent molecular weights of these slower-migrating species were 
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increased by roughly 20 kDa compared to the unmodified proteins, which is 
characteristic for the modification of substrate proteins with a single HisSUMO moiety 
(Hoege et al., 2002; Psakhye and Jentsch, 2012). Notably, only a small fraction of 
each SUMO substrate was modified at steady state and SUMOylated protein species 
could not be detected in total cell extracts. 
 
 
 
Figure 7. A number of mitochondrial matrix proteins are modified by SUMO in vivo. (A) Schematic 
depiction of the experimental design used to analyze the SUMOylation of individual proteins. Total cell 
extracts (Inputs) were prepared by TCA precipitation. SUMO conjugates were purified by denaturing 
Ni-NTA pull-downs (Ni-NTA PD) from cells expressing HisSUMO from the ADH1 promoter. Proteins were 
separated by SDS-PAGE on 12 % Bis-Tris gels and analyzed by western blotting using specific 
antibodies. (B) Identification of Ilv6 as SUMO substrate. Denaturing Ni-NTA pull-downs (Ni-NTA PD) 
were performed to isolate HisSUMO conjugates from different yeast strains. Cells expressing HisSUMO 
from the ADH1 promoter or/and Ilv6 fused to a C-terminal 3HA epitope from the endogenous promoter 
are indicated. HisSUMO conjugates and proteins from total cell extracts (Inputs) (prepared by TCA 
precipitation) were separated on 12 % Bis-Tris gels and analyzed by western blotting using HA epitope- 
and Pgk1-specific antibodies. Pgk1 SUMOylation was analyzed to control for pull-down efficiency. 
Levels of unmodified Pgk1 served as loading control. (C) Identification of Adh3 as SUMO substrate. 
Similar to (B) but with cells expressing C-terminally 3HA-tagged Adh3 from the endogenous promoter. 
(D) Identification of Mrpl23 as SUMO substrate. Similar to (B) but with cells harboring a plasmid that 
expresses C-terminally 3HA-tagged Mrpl23 from the ADH1 promoter. 
 
3.1.2 SUMOylation of mitochondria-targeted proteins is mediated by specific 
SUMO E3 ligases 
In most cases, the SUMOylation of substrate proteins in vivo is strongly dependent 
on SUMO E3 ligases. To test whether the SUMOylation of mitochondria-targeted 
proteins is stimulated by distinct SUMO E3 ligases, the levels of SUMO-modified HA-
tagged Ilv6 were analyzed in cells lacking one of the known SUMO E3 ligases Siz1 
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(Δsiz1), Siz2 (Δsiz2), Zip3 (Δzip3) or expressing a ligase-defective mutant variant of 
the essential SUMO E3 enzyme Mms21 (mms21-11). Western blot analysis of 
SUMO conjugates isolated by HisSUMO Ni-NTA pull-downs indicated that the 
SUMOylation of Ilv6 is mediated by Siz1 and to a minor extend by Siz2 (Figure 8A). 
By contrast, Ilv6 SUMOylation was unaltered upon deletion of Zip3, which is 
consistent with its meiosis-specific functions (Agarwal and Roeder, 2000; Cheng et 
al., 2006; Eichinger and Jentsch, 2010). Different from the other E3 ligase mutants, 
mms21-11 cells displayed lower Ilv6 protein levels in total cells extracts. Moreover, 
SUMOylation of both Ilv6 and Pgk1 was impaired in samples from these cells. Since 
it appears unlikely that the cytosolic enzyme Pgk1 is SUMOylated by the strictly 
nuclear E3 ligase Mms21, this suggested an indirect effect that was probably related 
to the slow growth phenotype of this particular mutant (Figure 8B). 
 
 
 
Figure 8. Ilv6 SUMOylation is catalyzed by the SUMO E3 ligases Siz1 and Siz2. (A) Ilv6 
SUMOylation is specifically reduced in cells lacking Siz1 or Siz2. Denaturing HisSUMO Ni-NTA pull-
downs (Ni-NTA PD) from wild type cells, mutants lacking one of the known SUMO E3 ligases Siz1 
(Δsiz1), Siz2 (Δsiz2), Zip3 (Δzip3) or expressing a mutant variant of the SUMO E3 ligase Mms21 that 
lacks E3 ligase activity (mms21-11). All cells used in (A) express C-terminally 3HA-tagged Ilv6 from the 
endogenous promoter. Cells expressing HisSUMO from the ADH1 promoter are indicated. (B) Growth 
phenotypes of yeast strains used in (A). Five-fold serial dilutions of cells were spotted on YPD plates 
and incubated at 30°C for 2 days. 
 
Indeed, Ilv6 SUMOylation was virtually absent in double deletion mutants lacking 
both Siz1 and Siz2 (Δsiz1 Δsiz2) (Figure 9A), demonstrating that these two SUMO 
E3 ligases of the conserved Siz/PIAS protein family mediate the modification of Ilv6. 
Strikingly, with highly similar contributions, Siz1 and Siz2 also catalyzed the 
SUMOylation of Adh3 (Figure 9B) and Mrpl23 (Figure 9C), demonstrating that all 
mitochondria-targeted SUMO substrates identified in this study require an identical 
combination of SUMO E3 ligases for modification. 
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Figure 9. SUMOylation of mitochondria-targeted proteins requires the combined activity of the 
SUMO E3 ligases Siz1 and Siz2. (A) Ilv6 SUMOylation is virtually absent in cells lacking the SUMO E3 
ligases Siz1 and Siz2. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from wild type cells, 
mutants lacking Siz1 (Δsiz1), Siz2 (Δsiz2) and the double deletion mutant (Δsiz1 Δsiz2). (B) 
SUMOylation of Adh3 is almost undetectable in cells lacking the SUMO E3 ligases Siz1 and Siz2. 
Similar to (A) but with cells expressing C-terminally 3HA-tagged Adh3 from the endogenous promoter. 
(C) SUMOylation of Mrpl23 almost undetectable in cells lacking the SUMO E3 ligases Siz1 and Siz2. 
Similar to (A) but with cells harboring a plasmid that expresses C-terminally 3HA-tagged Mrpl23 from 
the ADH1 promoter. 
 
3.1.3 Identification of SUMO acceptor sites of mitochondria-targeted proteins 
SUMO substrates are often modified at one or multiple specific lysine residues. To 
identify the SUMO acceptor sites of Ilv6, all lysine residues of the protein were 
individually replaced by arginine. The corresponding KR mutant variants were tagged 
with C-terminal 3HA epitopes and expressed from the endogenous promoter in 
yeast. Among these variants, a mutant at Lys 260 (K260R) strongly reduced the 
levels of Ilv63HA-SUMO conjugates (Figure 10A), indicating that this particular lysine 
residue is the major SUMO attachment site of Ilv6. Sequential replacement of three 
additional lysine residues by arginine (K218R, K284R and K296R) further decreased 
the SUMOylation of Ilv6 in a stepwise manner. Accordingly, a mutant variant lacking 
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all four lysine residues (ilv63HA-K218R, K260R, K284R, K296R termed ilv63HA-4KR) 
was almost completely refractory to SUMOylation (Figure 10A and B). 
 Interestingly, analysis of Ilv6 SUMOylation using different KR mutant variants 
also revealed that modification of individual lysine residues of Ilv6 gives rise to 
differentially migrating protein species (Figure 10A). This suggests that the relative 
electrophoretic mobility of Ilv6-SUMO conjugates is dependent on the position of the 
modified lysine residues. Similar findings have been made for the SUMO substrates 
PCNA (Hoege et al., 2002) and Rad52 (Sacher et al., 2006), further confirming that 
the gel migration behavior of SUMO-protein conjugates not only depends on their 
size but also on the positions of the branched peptides. 
 Ilv6 contains two lysine residues (K158 and K218) embedded within a 
ΨKX(D/E)-type SUMOylation consensus motif. However, only one of these lysine 
residues (K218) was detectably SUMOylated in wild type cells and the modification 
of Lys 218 occurred with much lower efficiency than the SUMOylation of the non-
consensus Lys 260. Thus, the SUMOylation of Ilv6 is not restricted to SUMOylation 
consensus sites and occurs with even stronger preference at alternative lysine 
residues. 
 In case of Adh3, computational analysis using the GPS-SUMO software 
(Zhao et al., 2014) identified two potential SUMO attachment sites at Lys 305 and 
Lys 375. Individual and simultaneous replacement of these two lysine residues by 
arginine revealed a prominent modification of Adh3 at Lys 305, which is embedded 
within a SUMOylation consensus motif (Figure 10C and D). 
 Remarkably, all SUMO attachment sites identified in Ilv6 and Adh3 appeared 
to exclusively localize to C-terminal segments of these proteins (Figure 10B and D). 
Similarly, SUMOylation of C-terminal acceptor sites could be observed for Mrpl23, 
where the simultaneous mutation of the two most C-terminal lysine residues (K155 
and K163) to arginine reduced the levels of Mrpl233HA-SUMO conjugates by around 
50 % (Figure 10E and F). Additionally, SUMO conjugates of the resulting mutant 
variant (mrpl233HA-K155R, K163R) showed an altered and more dispersed 
electrophoretic mobility compared to conjugates of the wild type protein. This 
suggests that Lys 155 and Lys 163 indeed serve as primary SUMO attachment sites 
of Mrpl23 and that alternative lysine residues are modified when Lys 155 and 
Lys 163 have been experimentally removed. Notably, neither of these two lysine 
residues is embedded within a ΨKX(D/E)-type sequence motif, confirming that 
mitochondria-targeted SUMO substrates are modified at both consensus and non-
consensus SUMOylation sites. 
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Figure 10. The SUMO acceptor lysines of mitochondria-targeted proteins. (A) Ilv6 SUMOylation 
occurs at multiple lysine residues. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from cells 
harboring plasmids that express C-terminally 3HA-tagged Ilv6 or various KR mutant variants as 
indicated from the endogenous promoter. (B) Schematic representation of the Ilv6 protein indicating the 
positions of four SUMO acceptor lysines (grey triangles). The mitochondrial targeting sequence (MTS) is 
depicted in green, the ACT (aspartate kinase, chorismate mutase and TyrA) domain in blue and the 
ALS_ss_C (acetolactate synthase small subunit C-terminus) domain in black. (C) Adh3 is SUMOylated 
at Lys 305 (K305). Similar to (A) but with cells harboring plasmids expressing C-terminally 3HA-tagged 
Adh3 or the indicated KR mutant variants from the GAL1 promoter. (continued on next page) 
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(legend to Figure 10 continued) (D) Schematic representation of the Adh3 protein and the position of 
the SUMO acceptor site at Lys 305. The mitochondrial targeting sequence (MTS) is depicted in green, 
the GroES-like domain in grey and the zinc-binding domain in blue. (E) Identification of two SUMO 
acceptor lysines in Mrpl23. Similar to (A) but with cells harboring plasmids expressing C-terminally 3HA-
tagged Mrpl23 or the indicated KR mutant variants from the ADH1 promoter. (F) Schematic 
representation of the Mrpl23 protein and the localization of two SUMO acceptor sites (Lys 155 and 
Lys 163). The mitochondrial targeting sequence is depicted in green and the ribosomal L13 domain in 
grey. 
 
3.1.4 SUMOylation of mitochondria-targeted proteins is import-independent 
All proteins identified as novel SUMO substrates in this study are nuclear-encoded 
proteins. These proteins are synthesized on cytosolic ribosomes and subsequently 
imported into mitochondria. Hence, the important questions arose, at which 
biogenesis stage the SUMOylation of mitochondria-targeted proteins occurs and 
whether the modification is linked to their import into the mitochondrial matrix. 
 To clarify theses question, a series of import-deficient mutant Ilv6 variants 
lacking the N-terminal MTS were generated (Figure 11A). The design of these 
variants was based on database annotations (UniProt) and computational MTS 
prediction, which suggested two potential processing sites of the Ilv6 prepeptide after 
Cys 24 (UniProt and TargetP) and Val 94 (MitoProt II), respectively. Moreover, as an 
“intermediate” between the two predictions, an Ilv6 variant lacking amino acid 2-55 
was generated. 
 Microscopic analysis of different Ilv6 constructs fused to GFP confirmed the 
mitochondrial localization of full-length Ilv6 and demonstrated that removal of an N-
terminal 24-amino-acid peptide (Δmts-ilv6GFP variant I) was sufficient to prevent 
mitochondrial import (Figure 11B). The presumably cytosolic localization of the 
resulting deletion mutant is in line with a previous study on the catalytic subunit of 
yeast acetolactate synthase (Ilv2), which reported that MTS deletion causes a similar 
mislocalization of Ilv2 to the cytosol (Dasari and Kolling, 2011). 
 To subsequently analyze the SUMOylation of the import-deficient Ilv6 
variants, all truncation mutants were fused to C-terminal 3HA epitopes and 
expressed from the inducible GAL1 promoter. In the corresponding western blot 
assays, expression of full-length Ilv6 gave rise to a prominent double band 
representing the Ilv6 precursor and a faster-migrating mature form of Ilv6 (Figure 
12A). As expected, all N-terminally truncated Ilv6 mutants yielded single bands when 
detected with an HA-specific antibody (Figure 12A). Notably, the Ilv6 variant lacking 
amino acid 2-24 displayed a similar electrophoretic mobility as the mature form, 
suggesting that proteolytic processing of Ilv6 by MPP indeed occurs after or in close 
proximity to Cys 24. 
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Figure 11. Generation of import-incompetent mutant variants of a mitochondria-targeted protein. 
(A) Schematic representation of the Ilv6 protein and three different N-terminally truncated mutant 
variants lacking the MTS (Δmts-ilv6 variant I-III). The N-terminal prepeptide (according to UniProt 
annotation) is depicted in green, the ACT domain in blue and the ALS_ss_C domain in black. (B) 
Deletion of the N-terminal 24-amino-acid prepeptide of Ilv6 is sufficient to prevent mitochondrial import. 
Microscopic analysis of GFP fusion proteins of full-length Ilv6 and a mutant variant lacking the N-
terminal MTS (Δmts-ilv6 variant I). Yeast cell walls were visualized by calcofluor white staining. Scale 
bars represent 20 µm. 
 
Moreover, strikingly, western blot analysis of subsequently isolated HisSUMO 
conjugates demonstrated that all import-deficient variants of Ilv6 were efficiently 
SUMOylated, even at higher levels than the full-length protein (Figure 12A). Thus, 
the SUMO modification of Ilv6 is in fact independent of mitochondrial import and 
does not require the presence of an MTS. 
 Notably, Ilv63HA-SUMO conjugates isolated from strains expressing full-length 
Ilv6 exhibited a similar electrophoretic mobility compared to SUMOylated species of 
the Δmts-ilv63HA variant I. Assuming that SUMOylated Ilv6 precursors migrate slower 
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during gel electrophoresis, this suggests that Ilv6-SUMO conjugates possess a 
proteolytically processed N-terminus also in strains expressing the full-length 
substrate. Therefore, it is conceivable that C-terminally SUMOylated Ilv6 can initiate 
import normally, leading to removal of the N-terminal presequence by MPP in the 
matrix. 
 
 
 
Figure 12. SUMOylation of Ilv6 is independent of mitochondrial import. (A) Import-incompetent Ilv6 
mutant variants are efficiently SUMOylated. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from 
cells harboring plasmids that express C-terminally 3HA-tagged full-length Ilv6 or one of three N-
terminally truncated mutant variants as indicated. All protein variants are expressed from the GAL1 
promoter. To achieve similar protein levels, expression was induced for 30 min (full-length Ilv6) and 
60 min (variant I-III), respectively. Cells expressing HisSUMO from the ADH1 promoter are indicated. 
Ratios of the levels of SUMOylated vs. unmodified proteins were determined by western blot 
quantification using ImageJ (B and C) SUMOylation of import-deficient Ilv6 is stimulated by the SUMO 
E3 ligases Siz1 and Siz2. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from wild type cells, 
mutants lacking Siz1 (Δsiz1), Siz2 (Δsiz2) and the double deletion mutant (Δsiz1 Δsiz2). Cells are 
complemented with plasmids expressing the import-deficient Ilv6 mutant variant I (B) and variant III (C), 
respectively from the GAL1 promoter. Protein expression was induced for 60 min. (D) Identification of 
SUMO modification sites of import-incompetent Ilv6. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA 
PD) from cells harboring plasmids that express import-incompetent Ilv6 (variant I) or a mutant variant, in 
which four lysine residues are replaced by arginine (corresponding to the positions K218, K260, K284 
and K294 of full-length Ilv6). 
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However, a bulky modification like SUMO might be too large to allow threading 
through the narrow mitochondrial import pores and therefore could block the 
completion of mitochondrial import for steric reasons (see section 4.3). 
 Interestingly, when studied in further detail, the SUMOylation of import-
incompetent Ilv6 variants displayed similar characteristics as the modification of the 
full-length protein. In particular, the modification was also dependent on the E3 
ligases Siz1 and Siz2 (Figure 12B and C) and evidently targeted a largely 
overlapping set of SUMO acceptor sites (Figure 12D). 
 To further corroborate that the SUMOylation of mitochondria-targeted 
proteins is independent of mitochondrial import, Adh3 was analyzed as a second 
SUMO substrate. To this end, a C-terminally HA-tagged Adh3 variant lacking the N-
terminal MTS (amino acid 1-27) was generated (Δmts-adh33HA) (Figure 13A) and 
expressed from the GAL1 promoter in yeast. Both, full-length (Adh33HA) and N-
terminally truncated Adh3 (Δmts-adh33HA) gave rise to a single band in western blot 
assays. This indicates that also in this experimental system the vast majority of full-
length Adh3 species are imported into mitochondria and proteolytically processed by 
MPP in the matrix (Figure 13B). 
 Strikingly, Adh3 lacking the MTS was strongly SUMOylated, also at higher 
levels than the full-length protein (Figure 13B). This further confirmed that 
SUMOylation efficiently targets import-incompetent mutant variants of mitochondrial 
proteins. SUMOylation of Δmts-adh33HA yielded two species with distinctive 
electrophoretic mobility, suggesting the modification of this mutant variant occurs at 
two alternative lysine residues. Nevertheless, SUMOylation of both species was 
dependent on the combined activity of Siz1 and Siz2 (Figure 13C), thus exhibiting 
the same SUMO E3 ligase requirement as the modification of the full-length protein. 
Moreover, import-deficient Adh3 was preferentially modified at the same SUMO 
attachment site as the wild type protein and replacement of this particular lysine 
residue by arginine caused the loss of the more prominent, faster-migrating 
Δmts-adh33HA-SUMO conjugate (Figure 13D). 
 Taken together, several lines of evidence indicate that the SUMOylation of 
mitochondria-targeted substrates is generally import-independent. Mutant variants of 
mitochondrial proteins lacking a functional MTS are strongly SUMOylated and 
truncation of the MTS in fact enhances their modification. Moreover, in terms of E3 
ligase requirement and SUMO attachment sites, the SUMOylation of import-
incompetent substrate variants exhibits striking similarities to the modification of the 
full-length proteins. In conclusion, these findings could have important implications 
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for the SUMOylation of import-competent mitochondrial proteins and suggest that 
their modification probably occurs prior to import into the organelle. 
 
 
 
Figure 13. SUMOylation of Adh3 is independent of mitochondrial import. (A) Schematic 
representation of the Adh3 protein and an N-terminally truncated mutant variant lacking the MTS (Δmts-
adh33HA). The N-terminal prepeptide is depicted in green, the GroES-like domain in dark grey, the zinc-
binding domain in blue and the 3HA epitope in light grey. (B) Import-incompetent Adh3 is efficiently 
SUMOylated. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from cells harboring plasmids that 
express C-terminally 3HA-tagged full-length Adh3 (Adh33HA) or a mutant variant lacking the N-terminal 
MTS (Δmts-adh33HA). Cells were grown in galactose-containing medium, allowing the constitutive 
expression of all protein variants from the GAL1 promoter. Cells expressing HisSUMO from the ADH1 
promoter are indicated. Ratios of the levels of SUMOylated vs. unmodified proteins were determined by 
western blot quantification using ImageJ (C) SUMOylation of import-deficient Adh3 is stimulated by the 
SUMO E3 ligases Siz1 and Siz2. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from wild type 
cells, mutants lacking Siz1 (Δsiz1), Siz2 (Δsiz2) and the double deletion mutant (Δsiz1 Δsiz2). Cells 
were complemented with plasmids expressing the import-deficient Adh3 mutant variant under control of 
the GAL1 promoter and grown in galactose-containing medium. (D) Import-incompetent Adh3 is 
predominantly SUMOylated on Lys 305 (K305). Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) 
from cells harboring plasmids that express import-incompetent Adh3 (Δmts-adh33HA WT) or a lysine 
mutant resulting from the replacement of one lysine residue by arginine (corresponding to position K305 
of full-length Adh3) (Δmts-adh33HA-K305R). 
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3.2 SUMOylation of mitochondria-targeted proteins is regulated by 
cytosolic factors 
Posttranslational import of mitochondrial proteins often involves molecular 
chaperones or similar factors that maintain the import-competence of precursor 
proteins after their synthesis in the cytosol. Thus, the idea that the SUMOylation of 
mitochondria-targeted proteins occurs prior to import at a cytosolic biogenesis stage 
prompted the question whether the modification is regulated by cytosolic factors as 
well. 
3.2.1 SUMOylation of mitochondria-targeted proteins is linked to the HSP70 
system 
In yeast, strong evidence indicates an implication of SSA family chaperones in 
protein translocation into mitochondria (Deshaies et al., 1988; Murakami et al., 1988). 
SSA chaperones comprise four homologous proteins, Ssa1-4, and represent a major 
group of cytosolic HSP70s in S. cerevisiae. Although the deletion of all four Ssa 
proteins is lethal, expression of any single member of this family of chaperones is 
sufficient to maintain cell viability. Consistently, strains deleted for three out of four 
SSA genes (Δssa2 Δssa3 Δssa4) and harboring either wild type SSA1 or a 
temperature-sensitive allele (ssa1-45) (Becker et al., 1996) have been widely used to 
study HSP70 functions in yeast. 
 To test whether mitochondria-targeted protein SUMOylation is affected in 
SSA mutants, HisSUMO together with 3HA-tagged Ilv6 or Adh3 were expressed in 
wild type (DF5 yeast cells containing the same set of auxotrophic markers but 
expressing Ssa1-4), SSA1 and ssa1-45 cells. Consistent with results described in the 
previous sections of this study, HA-tagged Ilv6 gave rise to a double band in western 
blot assays, representing the unprocessed Ilv6 precursor and a faster-migrating 
mature form (Figure 14A). Notably, particularly ssa1-45 mutants displayed increased 
levels of the Ilv6 and Adh3 precursors (Figure 14A and B), indicating that Ssa 
proteins are required for efficient mitochondrial import of these proteins. This finding 
is consistent with previous studies, which reported an accumulation of mitochondrial 
precursor proteins in SSA mutant yeast strains (Becker et al., 1996; Deshaies et al., 
1988). 
 Strikingly, the SUMOylation patterns of both Ilv6 and Adh3 were also affected 
in ssa1-45 cells, which showed a strong accumulation of the SUMOylated Ilv6 and 
Adh3 precursor, respectively (Figure 14A and B). In both cases SUMOylation 
produced multiple slower-migrating species, suggesting that the proteins are perhaps 
modified at multiple sites. 
RESULTS 
 
 41 
 
 
Figure 14. SUMOylation of mitochondria-targeted proteins is increased in mutants of the SSA 
family of HSP70 chaperones. (A) SUMOylated Ilv6 precursor species strongly accumulate in ssa1-45 
chaperone mutant cells. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from wild type (SSA1 
SSA2 SSA3 SSA4 in DF5 background), SSA1 (SSA1 Δssa2 Δssa3 Δssa4) and ssa1-45 (ssa1-45 Δssa2 
Δssa3 Δssa4) cells. C-terminally 3HA-tagged Ilv6 is expressed from the endogenous promoter and 
HisSUMO from the ADH1 promoter. Bands corresponding to (monoSUMOylated) precursor protein (p) 
and the (monoSUMOylated) mature (m) form are labeled. (B) Singly and perhaps multiply SUMOylated 
Adh3 precursor protein species strongly accumulate in ssa1-45 mutant cells. Similar to (A) but with cells 
expressing C-terminally 3HA-tagged Adh3 from the endogenous promoter. 
 
In comparison to the entirely cytosolic Δmts-adh3 mutant (Figure 13), the apparent 
multi-site modification of Adh3 was much more pronounced in ssa1-45 cells. Thus, 
the increased levels of SUMOylated mitochondria-targeted substrates were probably 
not a mere result of the elevated levels of cytosolic precursor proteins. Consistently, 
in relation to the total Ilv6 precursor levels, the corresponding SUMOylated form also 
specifically accumulated in the ssa1-45 background. 
 To further corroborate that the SUMOylation of mitochondrial substrates is 
specifically induced in SSA mutants, Ilv6 SUMOylation was analyzed in SSA1 and 
ssa1-45 cells reconstituted with a plasmid-borne copy of wild type Ssa1 expressed 
under control of the ADH1 promoter. Importantly, expression of Ssa1 rescued the 
slow-growth phenotype of ssa1-45 cells at 25°C and largely restored viability at 37°C 
(Figure 15A). Consistently, Ssa1 expression efficiently reduced Ilv6 precursor 
SUMOylation in both SSA1 and ssa1-45 cells (Figure 15B). By contrast, under the 
same conditions, total SUMO conjugate levels were largely unaffected, confirming 
that the SUMOylation of Ilv6 is selectively altered in cells lacking functional SSA 
HSP70s. 
 In summary, these data indicate that the SUMOylation of mitochondria-
targeted proteins is indeed regulated by SSA family chaperones, specifically linking 
this cytosolic HSP70 system to the regulation of protein SUMOylation in yeast. 
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Figure 15. The SUMOylation of Ilv6 is specifically affected by Ssa1. (A) Ectopic expression of Ssa1 
rescues the lethality of ssa1-45 mutant cells at the restrictive temperature (37°C). SSA1 (SSA1 Δssa2 
Δssa3 Δssa4) and ssa1-45 (ssa1-45 Δssa2 Δssa3 Δssa4) cells were complemented with plasmids 
expressing wild type Ssa1 from the ADH1 promoter. Five-fold serial dilutions of cultures grown over 
night at 25°C (adjusted to OD600 = 1) were spotted on SC-HIS agar plates and incubated at 25°C for 2 
days and 37°C for 3 days. (B) Expression of wild type Ssa1 reduces Ilv6 precursor SUMOylation in 
SSA1 and ssa1-45 cells. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from SSA1 and ssa1-45 
cells complemented with plasmids that express wild type Ssa1 from the ADH1 promoter. C-terminally 
3HA-tagged Ilv6 was expressed from the endogenous promoter and HisSUMO was expressed from the 
ADH1 promoter. Total SUMO conjugate levels were analyzed by probing total cell extracts (Inputs) with 
Smt3-specific polyclonal antibodies. Levels of wild type Ssa1 were analyzed using an HSC70/HSP70-
specific monoclonal antibody (BB70) that fails to detect the ssa1-45 mutant protein. Bands 
corresponding to the (monoSUMOylated) precursor protein (p) and the (monoSUMOylated) mature (m) 
form are labeled. 
 
3.2.2 Increased range of SUMO acceptor sites in SSA mutant cells 
The detection of probably multiSUMOylated Ilv6 and Adh3 species in ssa1-45 cells 
prompted the question whether these substrates are modified on an extended set of 
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SUMO acceptor sites. To test this hypothesis, an Ilv6 lysine mutant, which lacks the 
four major SUMO attachment sites mapped under unperturbed conditions (ilv63HA-
4KR) (Figure 10A), was expressed in chaperone mutant cells. Strikingly, the 
precursor form of this Ilv6 variant was indeed considerably SUMOylated in SSA 
mutants, particularly in the ssa1-45 background (Figure 16A). Moreover, a similar 
effect could be observed by analysis of Adh3 SUMOylation using a mutant variant 
lacking Lys 305 (adh33HA-K305R) (Figure 16B). 
 
 
 
Figure 16. Functional impairment of the SSA HSP70 chaperone system increases the range of 
the SUMO acceptor sites in mitochondria-targeted proteins. (A) The ilv63HA-4KR lysine mutant 
(K218R, K260R, K284R, K294R) is substantially SUMOylated at alternative lysine residues in ssa1-45 
cells. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from SSA1 and ssa1-45 mutants. Cells 
were complemented with plasmids that express C-terminally 3HA-tagged wild type Ilv6 or a 
corresponding lysine mutant (4KR) from the ADH1 promoter. Expression of HisSUMO under control of 
the ADH1 promoter is indicated. Bands corresponding to the (monoSUMOylated) precursor protein (p) 
and the (monoSUMOylated) mature (m) form are labeled. (B) An Adh3 lysine mutant at Lys 305 is 
SUMOylated at alternative SUMO attachment sites in ssa1-45 cells. Similar to (A) but with cells 
harboring plasmids that express C-terminally 3HA-tagged wild type Adh3 or a corresponding lysine 
mutant at Lys 305 from the TDH3 promoter. 
 
 To gain deeper insights into the positions of Ilv6 SUMO acceptor sites in 
ssa1-45 cells, the 4KR mutant variant was subjected to additional rounds of 
mutagenesis, thereby further replacing several lysine residues by arginine in a 
stepwise manner. This approach indeed facilitated the identification of further Ilv6 
lysine residues (K116, K158 and K202), which are specifically SUMOylated in the 
SSA1 mutant background (Figure 17A and B). Moreover, the electrophoretic mobility 
of the corresponding SUMO conjugates indicated that exclusively Ilv6 precursors but 
not the mature form are modified at these sites. Thus, functional impairment of the 
SSA HSP70 system not only causes an increased SUMOylation of mitochondria-
targeted substrate precursors but - compared to wild type cells - also leads to 
modification of an extended set of SUMO attachment sites. 
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Figure 17. Identification of SUMO attachment sites of Ilv6 modified in chaperone mutant cells. (A) 
Schematic representation of Ilv6 and the positions of lysine residues within the protein (indicated by red 
triangles). (B) SUMOylation of Ilv6 occurs at multiple and widely distributed lysine residues in ssa1-45 
cells. Denaturing HisSUMO Ni-NTA pull-downs (Ni-NTA PD) from SSA1 and ssa1-45 mutants. Cells 
were complemented with plasmids that express C-terminally 3HA-tagged wild type Ilv6 or one of several 
corresponding lysine mutants as indicated from the ADH1 promoter. Bands corresponding to the 
(monoSUMOylated) precursor protein (p) and the (monoSUMOylated) mature (m) form are labeled. 
 
3.2.3 Mitochondrial precursor proteins harbor N-terminal HSP70 binding sites 
The finding that SUMOylation of mitochondria-targeted proteins is linked to the SSA 
subfamily of HSP70s raised the questions how functional impairment of this 
chaperone system leads to an increased and apparently less selective modification 
of multiple lysine residues. Interestingly, it has been reported recently that the 
phenotypes of the ssa1-45 allele are caused by an impaired substrate binding activity 
of the corresponding ssa1-45 mutant protein (Needham et al., 2015). It is therefore 
conceivable that association of mitochondrial preproteins with chaperones not only 
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confers import competence but could also shield them from SUMO conjugation. 
Notably, a further potentially relevant finding in this context was the detection of 
exclusively C-terminal SUMO attachment sites in wild type cells (Figure 10). These 
observations gave rise to the hypothesis that chaperones may bind to N-terminal 
protein segments of mitochondrial preproteins and thereby particularly prevent the 
SUMOylation of N-terminal lysine residues. Hence, it seemed plausible that 
mitochondrial precursor proteins harbor N-terminal Ssa1 binding sites. 
 To further address this idea, peptides derived from the primary structure of 
Ilv6 were screened for Ssa1 binding. To this end, a cellulose membrane-bound 
peptide array covering the entire Ilv6 sequence was synthesized using SPOT 
synthesis. Based on a protocol originally used to determine the substrate specificity 
of bacterial DnaK (Rudiger et al., 1997), the array was composed of 13mer peptides 
overlapping by 10 amino acid residues. 
 To identify peptides harboring Ssa1 binding sites, the peptide scan was then 
incubated with recombinant GST-Ssa1 under ATP-free conditions followed by the 
detection of membrane-bound Ssa1 using a GST-specific antibody. This approach 
indeed revealed Ssa1 binding to multiple Ilv6 peptides, several of them located within 
N-terminal segments of the protein (Figure 18). 
 
 
 
Figure 18. Ilv6 harbors Ssa1 binding sites within its N-terminus. A peptide scan covering the entire 
Ilv6 amino acid sequence was screened for Ssa1 binding. The peptide array was incubated with 
recombinant GST-Ssa1 and Ssa1 binding was detected with GST-specific antibodies coupled to HRP. 
N-terminal residues of the peptides on the first spots of each row (left) are indicated. Two peptides 
reported to bind the bacterial HSP70 DnaK served as reference peptides (positive control A: 
AKTLILSHLRFVV and positive control B: VVHIARNYA) (McCarty et al., 1996). A peptide representing 
the 13 N-terminal amino acids of firefly luciferase served as negative control (Rudiger et al., 1997). 
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Moreover, remarkably, Ssa1 binding sites were also located at the extreme N-
terminus of Ilv6, suggesting that its MTS might directly interact with HSP70s in vivo. 
 Taken together, compelling evidence indicates an involvement of the SSA 
chaperone system in the regulation of mitochondria-targeted protein SUMOylation. 
Moreover, the data presented in this study support a model in which binding of Ssa 
proteins to mitochondrial precursors in the cytosol not only restricts their 
SUMOylation but also affects their modification in terms of site selectivity. 
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3.3 Degradation of SUMOylated mitochondria-targeted proteins by a 
proteasome-dependent pathway 
3.3.1 SUMO-modified species of mitochondria-targeted proteins accumulate 
in proteasome mutants 
Several results obtained during this study indicate that in cells with impaired SSA 
chaperone activity, SUMOylation particularly targets cytosolic precursors of 
mitochondrial proteins. Such precursor proteins are generally considered as 
aggregation-prone (Endo et al., 1995a) and prone to degradation by cellular 
proteases (Mihara and Omura, 1996a; Neupert, 1997; Pfanner and Neupert, 1990; 
Schatz and Dobberstein, 1996). Thus, since SUMO has been implicated in 
aggregate handling and the degradation of aggregation-prone proteins in the past 
(see section 1.3.3), it seemed conceivable that the SUMOylation of mitochondria-
targeted proteins plays a role in protein quality control as well. In particular, the 
question arose whether SUMOylation targets aggregation-prone pools of 
mitochondrial precursor proteins and whether the levels of the corresponding SUMO 
conjugates are regulated by proteasomal degradation. 
 In a first attempt to evaluate this hypothesis, the SUMOylation of Ilv6 and 
Adh3 was analyzed in proteasome mutant cells expressing a hypomorphic variant of 
Rpt6 (cim3-1), one of six ATPase subunits within the 19S regulatory particle of the 
26S proteasome (Ghislain et al., 1993). Interestingly, cim3-1 cells showed mildly 
increased levels of the Ilv6 and Adh3 precursors (Figure 19A and B), suggesting that 
mitochondrial protein import might be less efficient in proteasome mutants. 
Alternatively, this could be indicative of a continuous turnover of small pools of 
mistargeted mitochondrial proteins in vivo, which would be blocked upon proteasome 
inhibition. 
 Strikingly, proteasome impairment also affected the SUMOylation of 
mitochondria-targeted proteins and SUMO-modified precursors of Ilv6 and Adh3 
strongly accumulated in cim3-1 cells (Figure 19A and B). SUMOylation of either 
substrate gave rise to multiple species, highly resembling the SUMO conjugate 
patterns observed in the SSA mutant backgrounds (Figure 14). This suggests that 
upon proteasome impairment both Ilv6 and Adh3 are perhaps modified at multiple 
sites. Likewise, the pattern of Mrpl233HA-SUMO conjugates was noticeably altered in 
cim3-1 cells, indicating a strong accumulation of singly and multiply SUMOylated 
species (Figure 19C). However, since the N-terminal prepeptide of Mrpl23 comprises 
only four amino acid residues (Figure 10F), a discrimination between the precursor 
and the processed form could not be made for this particular substrate. 
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Figure 19. Proteasome impairment causes a strong accumulation of SUMOylated species of 
mitochondria-targeted proteins. (A) Multiple SUMOylated Ilv6 species, particularly SUMOylated 
precursor species, accumulate in proteasome mutants (cim3-1). Denaturing HisSUMO Ni-NTA pull-
downs (Ni-NTA PD) from wild type and cim3-1 cells expressing C-terminally 3HA-tagged Ilv6 from the 
endogenous promoter. Expression of HisSUMO from the ADH1 promoter is indicated. Bands 
corresponding to the (monoSUMOylated) precursor protein (p) and the (monoSUMOylated) mature (m) 
form are labeled. (B-C) Increased SUMOylation of Adh3 (B) and Mrpl23 (C) in cim3-1 cells. Similar to 
(A) but with cells expressing C-terminally 3HA-tagged Adh3 from the endogenous promoter (B) or cells 
harboring plasmids that express C-terminally 3HA-tagged Mrpl23 from the ADH1 promoter (C). 
 
In any case, decreased proteasome activity appears to generally result in increased 
levels of SUMOylated mitochondria-targeted substrates and also leads to the 
detection of species simultaneously modified at multiple lysine residues. 
 Several findings described in this study demonstrate that the SUMOylation of 
mitochondria-targeted substrates is independent of mitochondrial import. Thus, the 
question arose whether proteasome impairment causes an increased SUMOylation 
also of import-defective variants of mitochondrial proteins. To this end, an Adh3 
mutant variant lacking its MTS (Δmts-adh33HA) was expressed from the GAL1 
promoter in cim3-1 cells. Importantly, protein levels of this Adh3 variant were largely 
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similar in total cell extracts of wild type and proteasome mutant cells (Figure 20A). By 
contrast, the corresponding SUMO conjugates strongly accumulated upon 
proteasome impairment (Figure 20A). Similar to the full-length substrate (Figure 
19B), SUMOylation produced numerous slower-migrating species, suggesting that 
the modification occurs simultaneously at multiple sites. 
 To further investigate site selectivity in this context, the SUMOylation of wild 
type Δmts-adh33HA was compared to a lysine mutant, in which Lys 305 (K305) was 
replaced by arginine. Notably, all substrate variants were again expressed at largely 
identical levels in wild type and cim3-1 cells (Figure 20B). Western blot analysis of 
HisSUMO conjugates isolated from wild type cells confirmed that SUMOylation of 
Δmts-adh33HA yields at least two slower-migrating species under unperturbed 
conditions (Figure 20B, lane 2). One of these species resulted from the modification 
of Lys 305, which was again accompanied by the SUMOylation of additional lysine 
residues (Figure 20B, compare lane 2 and lane 3). In proteasome mutant cells 
(cim3-1), SUMOylation at Lys 305 gave rise to two distinct slower-migrating species 
and contributed to the formation of further high molecular weight species (Figure 
20B, compare lane 4 and 5). Moreover, SUMOylation at probably multiple alternative 
attachment sites was clearly detectable in cim3-1 cells, even when Lys 305 had been 
experimentally removed (Figure 20B, lane 5). 
 
 
 
Figure 20. Multiply SUMOylated species of import-incompetent Adh3 accumulate in proteasome 
mutants. (A-B) The SUMOylation of import-incompetent Adh3 (Δmts-adh33HA) is strongly affected in 
proteasome mutant cells, which display a strong accumulation of various SUMOylated species probably 
modified at multiple sites. Denaturing Ni-NTA pull-downs (Ni-NTA PD) from wild type and cim3-1 cells 
harboring plasmids that express Δmts-adh33HA or a lysine mutant (K305R; corresponding to K305 of full-
length Adh3) from the GAL1 promoter. Cells additionally expressing HisSUMO from the ADH1 promoter 
are indicated. 
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Thus, in summary, proteasome impairment affects the SUMOylation of mitochondria-
targeted proteins and their import-defective derivatives in two ways: (1) it causes a 
strong accumulation of SUMO-modified species and (2) results in the robust 
SUMOylation of sites, which are not noticeably modified in wild type cells. 
3.3.2 SUMOylation targets aggregation-prone species of mitochondria-
targeted proteins 
Mitochondrial preproteins are thought to adopt a rather loosely folded state in the 
cytosol to maintain import competence (Neupert, 1997). However, protein unfolding 
often leads to the exposure of hydrophobic peptide stretches, which are usually 
buried in the native structure of a protein. These structural changes not only provide 
a basis for the recognition of unfolded substrates by molecular chaperones but also 
favor non-native protein-protein interactions that cause protein aggregation. 
 To gain insights into the features of processed and unprocessed 
mitochondrial proteins in terms of solubility, cellular fractionation assays were 
performed. To this end, endogenous Ilv6 fused to a C-terminal 3HA-epitope was 
chosen as a model substrate since low but noticeable levels of the corresponding 
precursor protein were reproducibly detected in total cell extracts. In brief (see 
Materials and Methods for details), exponentially growing yeast cells were lysed in 
buffer containing 1 % of the non-ionic detergent Triton X-100. The lysates were 
precleared by centrifugation and the resulting total cell extracts (T) were fractionated 
to separate soluble (S) and insoluble pellet (P) fractions. Interestingly, when 
compared to the mature mitochondrial form, the Ilv6 precursor showed a 
substantially increased aggregation propensity (Figure 21) and the levels of insoluble 
precursor species were further increased when HSP70 (SSA1 and ssa1-45 cells) 
(Figure 21) or proteasome activity (cim3-1 cells) (Figure 22) was impaired. 
 
 
 
Figure 21. Increased aggregation propensity of a mitochondrial precursor protein. Ilv6 precursors 
are pronouncedly more aggregation-prone than the mature mitochondrial form. Total cell extracts (T) 
from wild type (DF5 background), SSA1 and ssa1-45 cells were fractionated by centrifugation to obtain 
soluble (S) and insoluble pellet (P) fractions. All strains used in the fractionation assay express C-
terminally 3HA-tagged Ilv6 from the endogenous and HisSUMO from the ADH1 promoter. Proteins were 
separated on 12 % Bis-Tris gels and analyzed by western blotting using HA epitope-specific, Smt3-
specific and Dpm1-specific antibodies. Bands corresponding to the precursor protein (p) and the mature 
(m) form are labeled. 
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 Remarkably, after a longer exposure, western blot analysis also indicated the 
presence of a single distinct, slower-migrating form of Ilv6 in the pellet fractions of 
cim3-1 cells (Figure 22A, black triangle). As judged from its electrophoretic mobility, 
the molecular weight of this species exactly matched the modification of HA-tagged 
Ilv6 with a single HisSUMO moiety. Indeed, expression of a GFPSUMO fusion protein 
as the only source of SUMO increased its apparent molecular weight by about 
30 kDa (Figure 22B), suggesting that substantial levels of SUMOylated Ilv6 
accumulate in the insoluble protein pool in cim3-1 cells. Thus, SUMO might act on 
aggregation-prone species of mitochondria-targeted proteins, which accumulate in 
insoluble cellular protein fractions when proteasomal clearance mechanisms are 
defective. 
 
 
 
Figure 22. Accumulation of SUMOylated Ilv6 in insoluble protein fractions of proteasome mutant 
cells. (A-B) Ilv6-SUMO conjugates (indicated by black triangles) are detectable in the insoluble pellet 
fractions of proteasome mutant cells (cim3-1). Total cell extracts (T) from wild type and cim3-1 cells 
were fractioned into soluble (S) and insoluble pellet (P) fractions. The strains used in (A) express 
HisSUMO from the ADH1 promoter and are derived from the original CMY826 (WT) and CMY763 
(cim3-1) backgrounds (Ghislain et al., 1993). Strains used in (B) were obtained by backcrossing the 
cim3-1 allele into the DF5 background and either express HisSUMO or GFPSUMO from the ADH1 
promoter. All strains carry a genomic allele encoding C-terminally 3HA-tagged Ilv6 under control of the 
endogenous promoter. Proteins were separated on 12 % Bis-Tris gels and analyzed by western blotting 
using HA epitope-specific and Dpm1-specific antibodies. Bands corresponding to the precursor protein 
(p) and the mature (m) form are labeled. 
 
3.3.3 Proteasome impairment affects the turnover of Ilv6-SUMO conjugates 
Recently, SUMO has been proposed to function as a modulator of protein 
aggregation, which facilitates the proteasomal degradation of insoluble proteins (Guo 
et al., 2014). To assess a potential turnover of Ilv6-SUMO conjugates in vivo, 
expression shut-off assays were combined with denaturing Ni-NTA pull-downs to 
directly monitor the levels of SUMOylated Ilv6 over time. In brief, exponentially 
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growing yeast cells expressing HisSUMO and epitope-tagged Ilv6 were treated with 
the translational inhibitor cycloheximide and HisSUMO conjugates were isolated from 
cells sampled after different times. In wild type cells, SUMOylated Ilv6 was indeed 
instable, showing a time-dependent turnover after the block of protein synthesis by 
cycloheximide (Figure 23A). By contrast, strikingly, Ilv63HA-SUMO conjugates were 
almost completely stabilized in cells defective in proteasomal degradation (cim3-1) 
(Figure 23B). Thus, proteasome activity is a crucial determinant for the SUMOylation 
dynamics of mitochondria-targeted proteins, suggesting the possibility that the 
corresponding SUMO-protein conjugates are directly targeted for proteasomal 
degradation. 
 
 
 
Figure 23. Dynamic, proteasome-dependent turnover of Ilv6-SUMO conjugates upon translation 
shut-off. (A) Time-dependent decrease of Ilv6-SUMO conjugate levels in wild type (WT) cells analyzed 
by expression shut-off assays. Cells were grown at 25°C and shifted to 37°C for 60 min prior to the 
addition of cycloheximide (CHX). Subsequently, samples for the isolation of HisSUMO conjugates by 
denaturing Ni-NTA pull-downs (Ni-NTA PD) and the preparation of total cells extracts (Inputs) were 
taken at the indicated time points. Pull-down efficiency was controlled by monitoring the levels of 
unconjugated HisSUMO using Smt3-specific antibodies. Bands corresponding to the (monoSUMOylated) 
precursor protein (p) and the (monoSUMOylated) mature (m) form are labeled. (B) Stabilization of Ilv6-
SUMO conjugate levels in proteasome mutants. Similar as in (A) but including proteasome mutant cells 
(cim3-1). All strains used in (A) and (B) express C-terminally 3HA-tagged Ilv6 from the endogenous and 
HisSUMO from the ADH1 promoter. 
 
3.3.4 Isopeptidase-resistant Ilv6-SUMO conjugates are degraded by a 
proteasome-dependent pathway 
Protein modification by SUMO is dynamic and in many cases regulated by SUMO-
specific isopeptidases. Additional layers of control are provided by proteasomal 
degradation pathways, which sometimes involve the action of SUMO-targeted 
ubiquitin ligases (STUbLs) (Tatham et al., 2008; Uzunova et al., 2007). Hence, the 
levels of SUMO-protein conjugates can be dynamically regulated by the balance of 
SUMO conjugation, deconjugation and proteasomal degradation. 
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 In the further course of this study, the question arose how SUMO 
deconjugation and proteasomal degradation each contribute to the SUMOylation 
dynamics of mitochondria-targeted proteins. Analysis of SUMO conjugates in yeast 
cells defective in SUMO deconjugation is, however, complicated by the fact that 
deletion of SUMO-specific isopeptidases is lethal (Δulp1) (Li and Hochstrasser, 
1999) or confers strong pleiotropic phenotypes (Δulp2) (Li and Hochstrasser, 2000). 
Thus, it seemed reasonable to interfere with SUMO deconjugation by an alternative 
experimental strategy. 
 
 
 
Figure 24. Generation and expression of an isopeptidase-resistant yeast SUMO variant. (A) 
Multiple sequence alignment of human SUMO1-4 and yeast Smt3. The position in which human 
SUMO4 displays a Q-to-P replacement compared to other SUMO isoforms is indicated (red letters 
marked by a red triangle). Multiple sequence alignment assembly was carried out using the EBI Clustal 
Omega web tool. (B) Expression of a mature SUMO-Q95P variant leads to an accumulation of multiple 
SUMO conjugates in yeast. Plasmid constructs expressing His-tagged yeast Smt3 with C-terminal 
double glycine motif (HisSUMOGG) from the GAL1 promoter are genomically integrated at the URA3 
locus. The amino acids corresponding to Gln 95 of wild type Smt3 are either Gln (WT) or Pro (Q95P). 
Cells were grown in raffinose-containing medium and expression of SUMO variants was induced by 
addition of galactose for the indicated periods of time. Total cell extracts were prepared and analyzed by 
western blotting using Smt3-specific antibodies. (C) Isopeptidase-resistant Ilv6-SUMO conjugates are 
highly unstable. Similar to (B) but including the western blot analysis of HisSUMO conjugates isolated by 
denaturing Ni-NTA pull-downs (Ni-NTA PD). C-terminally 3HA-tagged Ilv6 expressed from the 
endogenous promoter was detected with an HA epitope-specific antibody. 
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 Interestingly, it has been reported that human SUMO4 is refractory to the 
processing by SUMO isopeptidases due to the presence of a critical proline residue 
at position 90 (Owerbach et al., 2005) (Figure 24A). Likewise, introduction of 
homologous amino acid changes allows the transfer of isopeptidase resistance to 
other SUMO isoforms (Mukherjee et al., 2009; Owerbach et al., 2005). Expression of 
such SUMO variants with a mature C-terminus bypasses the requirement for SUMO 
proteases for the initial SUMO maturation and leads to the formation of 
“isopeptidase-resistant” SUMO-protein conjugates in (Mukherjee et al., 2009). 
 
 
 
Figure 25. SUMOylation mediates the degradation of mitochondria-targeted substrates by a 
proteasome-dependent pathway. (A) Ilv6-SUMO-Q95P conjugates are highly unstable in cells lacking 
known STUbLs. Wild type (WT) or isopeptidase-resistant (Q95P) HisSUMOGG variants (as described in 
Fig. 24) were expressed from the GAL1 promoter for the indicated periods of time in wild type (WT) cells 
and cells lacking Slx5/Slx8 (Δslx5 Δslx8) or Ris1 (Δris1). Cells were grown in raffinose-containing 
medium and protein expression was induced by the addition of galactose. Total cell extracts were 
prepared by TCA precipitation (Inputs) and HisSUMO conjugates were isolated by denaturing Ni-NTA 
pull-downs (Ni-NTA PD). (B) Pronounced stabilization of isopeptidase-resistant Ilv6-SUMO conjugates 
in proteasome mutant cells. Similar to (A) but including wild type (WT) and proteasome mutant cells 
(cim3-1). Expression of HisSUMOGG variants from the GAL1 promoter was induced for the indicated 
periods of time. Bands corresponding to the (monoSUMOylated) precursor protein (p) and the 
(monoSUMOylated) mature (m) form are labeled. 
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 Indeed, expression of an analogous mutant variant of mature yeast SUMO 
(HisSUMOGG-Q95P) from the galactose-inducible GAL1 promoter led to a remarkable 
increase in SUMO conjugate levels, including Pgk1-SUMO (Figure 24B and C). By 
contrast, strikingly, SUMOylated Ilv6 species did not accumulate under these 
conditions but were hardly detectable (Figure 24C), indicating that the modification of 
mitochondria-targeted proteins by isopeptidase-resistant SUMO could trigger their 
degradation. Since the proteasomal degradation of SUMO conjugates often involves 
SUMO-targeted ubiquitin ligases (STUbLs), it seemed plausible that this could be the 
case for mitochondria-targeted proteins as well. However, levels of SUMO-modified 
Ilv6 were not altered in yeast cells lacking known STUbLs (Δslx5 Δslx8 and Δris1) 
(Figure 25A), suggesting that the degradation of mitochondria-targeted SUMO 
substrates is based on an alternative mechanism. Indeed, Ilv6-SUMO-Q95P 
conjugates were substantially stabilized in proteasome mutant cells (cim3-1) (Figure 
25B), indicating that SUMOylated Ilv6 is degraded by a STUbL-independent 
proteasomal pathway. 
 In summary, the SUMOylation of Ilv6 and perhaps mitochondria-targeted 
proteins in general appears to be a dynamic PTM that ultimately leads to the 
degradation of the modified substrate pool by the proteasome. The underlying 
degradation mechanism does not require known STUbLs, suggesting the existence 
of a novel proteasomal pathway that mediates the clearance of specific SUMO 
conjugates in a STUbL-independent manner. 
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4 DISCUSSION 
This study identifies mitochondrial-targeted proteins as a novel group of SUMO 
substrates and provides a first in-depth analysis of the modification and its functional 
consequences. The SUMOylation of mitochondria-targeted proteins is enhanced in 
response to certain proteotoxic stresses and appears to ultimately serve as a trigger 
for proteasomal degradation. Hence, the present study not only provides unique 
insights into the SUMO-modified proteome but also reveals novel links of the SUMO 
system to cellular protein quality control. 
4.1 An unexpected group of novel SUMO substrates 
Posttranslational modification by SUMO has been extensively studied in the past. 
Generally, the detection of SUMOylated proteins is complicated by the fact that the 
modification frequently affects only a small percentage of a given target. However, 
mass spectrometry-based technologies have strongly boosted the field of SUMO 
proteomics and facilitated the identification a plethora of SUMO substrates in yeast 
and human cells (Hendriks and Vertegaal, 2016; Makhnevych et al., 2009). 
Consistent with early studies on the predominantly nuclear activities of the SUMO 
system (Rodriguez et al., 2001; Sternsdorf et al., 1999), the majority of SUMO 
targets appears to be nuclear proteins (Hendriks and Vertegaal, 2016; Wohlschlegel 
et al., 2004). Additionally, multiple lines of evidence indicate a function of SUMO 
enzymes in the cytosol and several cytosolic SUMO substrates have been reported 
(Geiss-Friedlander and Melchior, 2007; Martin et al., 2007b). By contrast, only a 
minute number of potential mitochondrial SUMO substrates have been suggested by 
previous studies (Denison et al., 2005; Hannich et al., 2005; Panse et al., 2004; 
Wohlschlegel et al., 2004; Wykoff and O'Shea, 2005; Zhou et al., 2004). In fact, at 
the onset of this study, the modification of mitochondrial proteins, particularly proteins 
of inner subcompartments, seemed unexpected for two major reasons: First, current 
knowledge about the SUMO system strongly indicates that intramitochondrial 
proteins are inaccessible to SUMO enzymes upon sorting (Flotho and Melchior, 
2013). Second, import of mitochondrial proteins occurs promptly and efficiently after 
their synthesis (Ungermann et al., 1996). Hence, hardly any pools of non-imported 
mitochondrial preproteins are detected in the cytosol in vivo (Ades and Butow, 
1980b; Fujiki and Verner, 1993; Hallermayer et al., 1977; Reid and Schatz, 1982). 
 Despite these apparent restrictions, this study provides striking evidence that 
several mitochondria-targeted proteins are modified by SUMO in vivo (Figure 7). 
Interestingly, these proteins differ substantially in terms of structure and function, 
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suggesting that SUMOylation does not specifically target a single, functionally distinct 
group of mitochondrial proteins. Notably, mitochondria-targeted substrates are 
modified at both ΨKX(D/E)-type consensus and non-consensus SUMOylation sites. 
The SUMOylation of non-consensus attachment sites has been reported previously 
for several yeast proteins (Hoege et al., 2002; Psakhye and Jentsch, 2012; Sacher et 
al., 2006), indicating that it might be a widespread phenomenon. At any rate, the 
discovery of mitochondria-targeted protein SUMOylation reveals unique new aspects 
of the SUMO system and its substrates. 
4.2 SUMOylation of mitochondria-targeted proteins occurs prior to 
import 
Consistent with SUMO’s known activities in the cytosol, it can be envisioned that a 
small pool of mitochondrial preproteins is accessible to SUMO enzymes prior to 
import. As a consequence, SUMOylation would be restricted to proteins that are 
posttranslationally sorted into mitochondria. Indeed, although evidence for 
cotranslational import has been provided for some proteins (Ades and Butow, 1980a; 
Fox, 2012; Fujiki and Verner, 1993), protein transport into mitochondria is thought to 
occur in a predominantly posttranslational manner (Chen and Douglas, 1987; Eilers 
and Schatz, 1986; Rassow et al., 1989; Wienhues et al., 1991). This concept is 
largely confirmed by a recent study, which globally assessed mitochondrial protein 
import by proximity-specific ribosome profiling (Williams et al., 2014). Although 
cotranslational translocation might be of particular relevance for inner membrane 
proteins, it has been reported that the majority of mitochondrial proteins, including 
Ilv6, Adh3 and Mrpl23, follows a predominantly posttranslational import route. Thus, 
it is generally conceivable that small pools of mitochondrial precursor proteins are 
targets of SUMO modifications in the cytosol. 
 Strong support for a model in which the SUMOylation of mitochondria-
targeted proteins occurs prior to import is also provided by data presented in this 
study, which demonstrate that their modification is independent of N-terminal MTSs. 
MTSs are known to form amphipathic alpha helices capable of interacting with the 
Tom20 import receptor at the outer mitochondrial membrane (Abe et al., 2000). 
Hence, MTS removal allows for the generation of import-incompetent mutant variants 
of mitochondrial proteins (Dasari and Kolling, 2011). Remarkably, compared to the 
full-length proteins, such variants (derived from Ilv6 and Adh3) are SUMOylated with 
strikingly similar characteristics in terms of E3 ligase requirement and SUMO 
attachment sites (Figure 12 and Figure 13). Thus, it is conceivable that, regarding 
their SUMOylation, MTS-lacking mutant proteins mimic an early biogenesis stage of 
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mitochondrial proteins and undergo a similar recognition by SUMO enzymes as their 
full-length counterparts. Moreover, for all substrates and substrate variants, 
SUMOylation is strongly dependent on the SUMO E3 ligase Siz1 (Figure 9, Figure 12 
and Figure 13). Since nuclear export of Siz1 into the cytosol is well-characterized in 
the context of septin SUMOylation (Makhnevych et al., 2007; Takahashi et al., 2008), 
it appears plausible that a cytosolic pool of Siz1 is responsible for the SUMOylation 
of mitochondria-targeted substrates as well. However, the modification of 
mitochondria-targeted substrates additionally involves the E3 ligase Siz2, suggesting 
a cytosolic function also for this particular enzyme. Consistently, small cytosolic pools 
of Siz2 have been reported by a study, which globally analyzed the localization of 
GFP fusion proteins in budding yeast (Huh et al., 2003). 
 Taken together, several lines of evidence indicate that SUMOylation of 
mitochondria-targeted proteins occurs prior to import, where the E3 ligases Siz1 and 
Siz2 modify small pool of substrates “en route” to mitochondria. Accordingly, the 
present study not only identifies an unanticipated group of SUMO substrates but also 
provides novel insights into the functions of SUMO E3 ligases in the cytosol. 
4.3 SUMOylation as a potential mechanism to regulate mitochondrial 
protein import 
Protein import into mitochondria involves the translocation of polypeptides through 
narrow proteinaceous channels. Virtually all types of preproteins enter mitochondria 
via a general entry gate, the TOM complex. The hydrophilic pores of this complex are 
formed by Tom40 subunits and have been determined to span a diameter of 2.0-2.5 
nm (Kunkele et al., 1998; Model et al., 2002; Schwartz and Matouschek, 1999). This 
is in line with the finding that mitochondrial proteins are imported in an unfolded and 
extended conformation (Rassow et al., 1990). Notably, proteins destined for the 
mitochondrial matrix have to additionally pass through the Tim23 channel in the inner 
mitochondrial membrane. With a diameter of 1.3-2.4 nm (Schwartz and Matouschek, 
1999; Truscott et al., 2001), this channel represents a further barrier restricting the 
mitochondrial import of folded proteins. Indeed, even small proteins such as model 
substrates containing dihydrofolate reductase fused to a mitochondrial targeting 
sequence are unable to complete import when their three-dimensional structure is 
stabilized (Eilers and Schatz, 1986; Rassow et al., 1989; Wienhues et al., 1991). 
 Given the fact that the SUMOylation of mitochondria-targeted proteins occurs 
most likely at a cytosolic biogenesis stage, the modification might have striking 
consequences for protein import. Ubiquitin family proteins are spherical molecules 
with diameters of approximately 2.5 nm (Renatus et al., 2006). Thus, it can be 
DISCUSSION 
 
 59 
envisioned that a modifier such as SUMO, which is tightly folded and covalently 
conjugated via a branched peptide, could stall the translocation of a modified 
substrate protein for steric reasons. Remarkably, a similar scenario has been 
reported for a model substrate obtained by crosslinking a folded 6 kDa protein moiety 
to the C-terminus of a mitochondrial precursor protein (Vestweber and Schatz, 1988). 
Moreover, importantly, this hypothesis is not contradictory to the observation that 
SUMO-modified species of substrates such as Ilv6 and Adh3 display mature N-
termini, which result from proteolytic processing by MPP in the mitochondrial matrix. 
Because these species are exclusively modified at C-terminal lysine residues (Figure 
10), it is possible that their N-termini reach the matrix-resident MPP while the 
SUMOylated C-termini of the proteins remain exposed to the cytosol (Figure 26). 
Notably, such partly imported translocation intermediates spanning both 
mitochondrial membranes have been described previously by several independent 
studies (Chen and Douglas, 1987; Cyr et al., 1995; Eilers and Schatz, 1986; Endo et 
al., 1995b; Kubrich et al., 1995; Rassow et al., 1989; Schleyer and Neupert, 1985; 
Schwaiger et al., 1987; Vestweber and Schatz, 1988). Moreover, it has been 
reported that a polypeptide segment comprising roughly 50 amino acid residues is 
sufficient to span both mitochondrial membranes (Rassow et al., 1990). 
 
 
 
Figure 26. Potential scenario explaining the N-terminal processing of C-terminally SUMOylated 
mitochondrial proteins. Due to the size of a folded SUMO moiety, it is conceivable that SUMOylation 
interferes with the complete import of mitochondria-targeted proteins. Nevertheless, SUMOylated 
species of mitochondria-targeted proteins display processed N-termini. This finding might be explained 
by the formation of translocation intermediates, for which the N-terminus reaches the mitochondrial 
processing peptidase (MPP) in the matrix while the SUMOylated C-terminus remains in the cytosol. 
TOM complex, translocase of the outer membrane; TIM23 complex, presequence translocase of the 
inner membrane; TIM44, membrane anchor for mitochondrial HSP70 (HSP); TIM44 and mtHSP70 are 
components of the PAM complex, the presequence translocase-associated motor. 
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Thus, a distance of more than 100 amino acid residues between the presequence 
cleavage site and the SUMO-modified lysine residues would allow the initiation of 
protein translocation into the matrix. Such a positioning of SUMO acceptor sites is 
indeed the case for all substrates described in this study (Figure 10) and 
SUMOylated lysine residues in closer proximity to the N-terminus were exclusively 
detected on precursor proteins (Figure 17). 
 Assuming that C-terminal SUMOylation arrests the translocation of a modified 
protein, two fates are conceivable for the stalled translocation intermediate: (1) the 
completion of import after the removal of the SUMO moiety by an isopeptidase or (2) 
the retrograde translocation into the cytosol after cleavage of the N-terminal 
presequence by MPP. Remarkably, such a retrotranslocation mechanism indeed 
exists and is involved in the biogenesis of certain enzymes such as fumarase in 
yeast. Fumarase is synthesized as a single translation product harboring an N-
terminal 24-amino-acid presequence. However, it is dually distributed between the 
mitochondrial matrix and the cytosol in vivo (Stein et al., 1994). Importantly, the 
cytosolic and mitochondrial enzyme populations display identical N-termini, which 
result from processing by MPP (Sass et al., 2001). Thus, initially all polypeptides are 
targeted to mitochondria, leading to the proteolytic removal of the N-terminal MTS. 
However, not all fumarase molecules are completely imported into the matrix. 
Following translation termination, rapid folding of fumarase’s C-terminus impedes 
import and induces the retrograde translocation of a fraction of polypeptides into the 
cytosol (Karniely and Pines, 2005; Knox et al., 1998; Stein et al., 1994). 
 Taken together, it appears conceivable that SUMOylation of mitochondria-
targeted proteins arrests their translocation at the import pore and that such 
intermediates have to be cleared by SUMO removal followed by the completion of 
import or by retrograde translocation into the cytosol. However, further experimental 
evidence is required to clarify whether one of these scenarios indeed arises in vivo. 
4.4 A partially hypothetical model for the regulation of mitochondria-
targeted protein SUMOylation by HSP70 chaperones 
Cytosolic factors, particularly chaperones of the HSP70 system, have been widely 
implicated in mitochondrial protein import (Hoogenraad et al., 2002; Mihara and 
Omura, 1996b; Mori and Terada, 1998). In yeast, HSP70s of the SSA family together 
with HSP40 co-chaperones are of particular importance for this process (see section 
1.2.4). In addition to their role in protein translocation, this study describes a novel 
function of SSA family chaperones in regulating the SUMOylation of mitochondria-
targeted proteins. In SSA mutant cells, SUMOylation of mitochondria-targeted 
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proteins is affected in two ways: (1) The levels of SUMOylated species, particularly of 
precursor proteins, are strongly increased and (2) the modification occurs at multiple 
attachment sites, including lysine residues, which are not detectably SUMOylated in 
wild type cells. Importantly, these alterations could be observed for different 
substrates, suggesting a general effect. 
 In combination, the analysis of SUMO attachment sites and Ssa1 binding 
sites within the amino acid sequence of one substrate (Ilv6) allows to propose a 
partially hypothetical model of how SUMOylation of mitochondria-targeted proteins is 
regulated by molecular chaperones. In particular, the detection of potential 
chaperone binding sites within the N-terminal presequence of Ilv6 suggests that MTS 
peptides may directly interact with HSP70s in vivo. The resulting formation of 
precursor-chaperone complexes might not only maintain the import competence of 
mitochondria-targeted proteins but perhaps also reduces their accessibility to SUMO 
enzymes. Moreover, a direct association of HSP70 proteins with the N-terminus of 
preproteins could additionally account for the preferential SUMOylation of C-terminal 
lysine residues under unperturbed conditions. 
 Notably, it has been shown recently that the ssa1-45 mutant protein, which 
has been used in the course of this study, is deficient in substrate binding (Needham 
et al., 2015). It is therefore conceivable that in ssa1-45 cells, SUMO enzymes target 
a pool of “free” mitochondrial precursor proteins, which are not incorporated into 
precursor-chaperone complexes. For these substrates, SUMOylation is not restricted 
by chaperone binding to N-terminal protein segments, thus potentially allowing the 
modification of a more extended set of lysine residues. 
 HSP70 chaperones are generally thought to preferentially interact with short 
hydrophobic peptide segments, which are usually buried in the native structure of a 
protein (Flynn et al., 1991; Rudiger et al., 1997; Zhu et al., 1996). Hence, at a first 
glance, HSP70 binding to N-terminal, positively charged signal peptides might 
appear unexpected. However, remarkably, it has been reported that the yeast 
HSP70 Ssa1 indeed binds mitochondrial presequences and that the interaction 
depends on the amphiphilicity of the presequence (Endo et al., 1996). Moreover, 
enrichment of basic amino acid residues has been shown for peptides interacting 
with multiple HSP70 proteins (Fourie et al., 1994; Rudiger et al., 1997). Accordingly, 
binding to HSP70 chaperones might be a general feature of mitochondrial 
presequences, which thereby not only mediate protein targeting but perhaps also 
contribute to the formation of precursor-chaperone complexes. 
 In summary, this study reveals novels aspects of HSP70 chaperones as 
central regulators of the early biogenesis of mitochondrial proteins. Besides their role 
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in the maintenance of import competence, data presented here also indicate a 
function of HSP70s in the regulation of mitochondria-targeted protein SUMOylation. 
4.5 Proteasomal degradation of SUMO conjugates by a STUbL-
independent mechanism 
It has become evident that SUMO and ubiquitin not always act independently of each 
other but that a complex interplay between the two conjugation systems exists 
(Liebelt and Vertegaal, 2016; Schimmel et al., 2008; Tatham et al., 2011). Crosstalk 
between the two pathways has been particularly revealed by the identification of 
SUMO-targeted ubiquitin ligases (STUbLs), which specifically mediate the 
ubiquitylation and proteasomal degradation of SUMO conjugates (Tatham et al., 
2008; Uzunova et al., 2007). Moreover, further levels of interdependent control may 
exist, for instance the regulation of ubiquitin conjugating enzymes (E2) (Pichler et al., 
2005) and ubiquitin E3 ligases (Novoselova et al., 2013) by SUMOylation. 
 In line with the discovery of proteasome-dependent pathways mediating the 
proteolytic turnover of SUMO conjugates, this study identifies mitochondrial proteins 
as a novel group of SUMO substrates regulated by proteasomal degradation. 
Notably, proteasomal protein degradation might be generally involved in the 
clearance of mislocalized or retrotranslocated mitochondrial proteins in the cytosol 
(Bragoszewski et al., 2013; Habelhah et al., 2004; Pearce and Sherman, 1997; 
Wrobel et al., 2015). However, SUMO appears to confer additional specificity for the 
recognition of a small pool of mitochondria-targeted proteins by the proteasome 
system. Experimental evidence supporting this notion is given by the finding that 
upon proteasome impairment, particularly SUMOylated mitochondrial precursor 
proteins strongly accumulate (Figure 19). Even more strikingly affected is the 
SUMOylation of import-incompetent Adh3. Overall protein levels of this substrate are 
largely similar in total cell lysates of wild type and proteasome mutant cells (Figure 
20). However, the corresponding SUMO conjugates strongly and specifically 
accumulate upon proteasome impairment (Figure 20). 
 Further evidence for the proteasomal degradation of SUMOylated pools of 
mitochondria-targeted proteins is demonstrated by the finding that SUMO-modified 
species become highly unstable when SUMO deconjugation is blocked (Figure 24). 
This is in stark contrast to multiple other SUMO conjugates including Pgk1, which 
strongly accumulate in cells expressing the isopeptidase-resistant SUMO-Q95P 
variant (Figure 24). Interestingly, these data also suggest that the SUMO conjugate 
levels of mitochondrial substrates observed in wild type cells are a result of dynamic 
SUMOylation and deSUMOylation. Additionally, it seems plausible that irreversible 
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SUMO attachment to mitochondria-targeted proteins leads to the rapid degradation 
of the corresponding SUMO conjugates. The underlying mechanism requires 
proteasome function, however, is evidently independent of known yeast STUbLs 
(Figure 25). At first glance, the degradation of SUMO conjugates independent of 
SUMO-specific STUbLs might appear unexpected. However, even in proteasome 
mutant cells, predominantly mono- and only to a minor degree diSUMOylated 
species of mitochondria-targeted proteins are detectable (Figure 19), suggesting that 
the degradation of these SUMO-protein conjugates does not involve SUMO chains. 
By contrast, most STUbLs harbor multiple SIMs that mediate cooperative binding of 
multiple SUMO units, thereby facilitating the preferential recognition of polySUMO 
chains (Rojas-Fernandez et al., 2014; Tatham et al., 2008; Uzunova et al., 2007). 
 In a model in which SUMO conjugates are degraded by a STUbL-
independent pathway, it remains unclear by which mechanism SUMO-modified 
substrates are recognized. One potential explanation is the existence of a novel, yet 
to be identified, ubiquitin E3 ligase, which possesses specificity for SUMOylated 
substrates. Alternatively, an intriguing possibility is the proteasomal clearance of 
SUMO conjugates independent of ubiquitylation. Notably, ubiquitin-independent 
proteasomal degradation has indeed been described for some substrates (Erales 
and Coffino, 2014). A further, potentially relevant, fact might be that mitochondrial 
precursor proteins are known to adopt a loosely folded state in the cytosol (Neupert, 
1997). It is therefore conceivable that mitochondria-targeted substrates become 
SUMOylated in an unfolded state and that the resulting branched peptide impairs 
further folding for steric reasons. The presence of SUMO attachment sites within 
functional domains (Figure 10) might indeed support this hypothesis. Thus, 
SUMOylation of mitochondria-targeted proteins could promote the exposure of 
degrons, which are recognized by ubiquitin E3 ligases generally involved in protein 
quality control, for instance Ubr1/2 (Eisele and Wolf, 2008; Nillegoda et al., 2010), 
San1 (Heck et al., 2010; Prasad et al., 2010), Rsp5 (Fang et al., 2014), Hul5 (Fang et 
al., 2011) or Doa10 (Metzger et al., 2008). 
4.6 SUMOylation of mitochondria-targeted proteins as example for 
SUMO-mediated protein quality control 
Data presented in this study support a model of a novel stress-induced SUMO 
pathway involved in the quality control of mitochondria-targeted proteins (Figure 27). 
In a first step, substrates of this pathway are recognized by the SUMO E3 ligases 
Siz1 and Siz2. Substrate selection occurs most probably prior to import and targets a 
small pool of proteins “en route” to mitochondria. As for many SUMO substrates, the 
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SUMOylation of mitochondria-targeted proteins appears to be dynamic, allowing the 
reversal of the modification and potentially the return to the usual import route into 
the organelle. In fact, under unperturbed conditions, the major pool of detectable 
SUMO-modified species appears to remain targeting-competent, leading to the 
initiation of import and cleavage of the N-terminal mitochondrial targeting signal. By 
contrast, upon stress, particularly impairment of the cytosolic HSP70 chaperone or 
the proteasome system, the SUMOylation of mitochondrial precursor proteins is 
strongly increased. Remarkably, under these conditions, the modification appears 
less stringent in terms of site-selectivity (Figure 16 and Figure 20). Interestingly, 
similar findings have been reported previously for the SUMOylation of c-Myc upon 
proteasome inhibition (Gonzalez-Prieto et al., 2015). Accordingly, it has been 
suggested that SUMOylation might generally act more promiscuously during stress 
(Hendriks and Vertegaal, 2016). 
 Altogether, these findings indicate a role for SUMO in general cytosolic 
protein quality control, which targets import-incompetent mitochondrial preproteins 
accumulating in response to specific stress conditions. Notably, mitochondrial 
precursor proteins are generally thought to be prone to aggregation and degradation 
(Neupert, 1997) and experimental evidence indeed indicates a pronounced presence 
of SUMO-modified precursor species in insoluble cell fractions of proteasome mutant 
cells (Figure 22). It is therefore conceivable that SUMOylation might chiefly target 
unfolded and potentially aggregation-prone mitochondrial preproteins. Finally, 
biochemical data presented in this study support a model in which SUMO attachment 
to mitochondria-targeted proteins ultimately serves as a degradative mark, which 
mediates the proteasomal clearance of the modified substrate pool. 
 Stepwise proteasome-dependent degradation mechanisms involving initial 
substrate SUMOylation have been reported by several previous studies (Guo et al., 
2014; Her et al., 2015; Kohler et al., 2015; Wang and Prelich, 2009). However, a 
largely unanswered question concerning these pathways is why SUMO is required in 
addition to ubiquitin. Intriguingly, a potential answer to this issue, at least in the 
context of protein quality control, might be provided by the finding that SUMO 
specifically promotes the proteasomal degradation of insoluble fractions of 
aggregation-prone proteins (Guo et al., 2014). It has been proposed that the SUMO 
system acts by a sequential mechanism based on the specific recognition of 
misfolded proteins by a SUMO E3 ligase and SUMO’s ability to increase the solubility 
of strongly aggregating proteins (Abeywardana and Pratt, 2015; Janer et al., 2010; 
Krumova et al., 2011; Mukherjee et al., 2009; Steffan et al., 2004; Zhang and Sarge, 
2008). 
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Figure 27. Model of a SUMO-mediated protein quality control pathway acting on mitochondria-
targeted substrates. Mitochondria-targeted SUMO substrates are nuclear-encoded proteins, which are 
synthesized on cytosolic ribosomes and subsequently imported into mitochondria. Under unperturbed 
conditions, mitochondrial protein import is efficient and the major pools of SUMO substrates with N-
terminal MTSs (depicted in red) are targeted to the organelle. In the cytosol, such proteins are probably 
bound by molecular chaperones (HSPs), which may directly interact with N-terminal MTSs. 
Consequently, only minor protein fractions are recognized by the SUMO E3 ligases Siz1 and Siz2 and 
SUMOylation occurs predominantly in the form of single SUMO moieties attached to C-terminal lysine 
residues. In response to certain proteotoxic stresses, the SUMOylation of mitochondria-targeted 
substrates is strongly increased. Under these conditions, SUMOylated precursor species of 
mitochondria-targeted proteins accumulate and the modification occurs at multiple sites, including lysine 
residues located in closer proximity to the N-termini of the substrates. Ultimately, the SUMOylation of 
mitochondria-targeted proteins mediates their degradation by a proteasome-dependent pathway. 
 
Thereby, SUMO could facilitate the clearance of insoluble protein aggregates, which 
are otherwise not efficiently degraded by the proteasome (Verhoef et al., 2002). 
Notably, the function as a solubility-promoting modification might be unique for 
SUMO and different from ubiquitin, which typically targets insoluble protein 
aggregates for degradation via autophagy (Kirkin et al., 2009a; Kirkin et al., 2009b; 
Lu et al., 2014; Pankiv et al., 2007). Moreover, the reversibility of SUMOylation could 
be the basis of the triage decision whether a misfolded substrate is selected for 
deSUMOylation and subsequent refolding or for degradation. In this regard, SUMO 
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appears to display striking parallels to the function of molecular chaperones. In fact, 
remarkably, it has been speculated that SUMO acts as a chaperone-like factor under 
certain circumstances (Seifert et al., 2015). 
 In conclusion, a role for SUMO as a solubility-promoting or chaperone-like 
factor is an intriguing new concept with strong implications for cellular protein quality 
control. Moreover, particular relevance is given for neurodegenerative diseases, 
which are widely associated with protein aggregation. Thus, future research will not 
only shed further light on SUMO’s role in proteostasis but might also provide 
possibilities for therapeutic intervention. 
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5 MATERIALS AND METHODS 
Common chemicals and reagents were purchased from BD Biosciences (San Jose, 
USA), Bio-Rad Laboratories (Hercules, USA), Cayman Chemical Company (Ann 
Arbor, USA), Merck Millipore (Darmstadt, Germany), MP Biomedicals (Santa Ana, 
USA), Roth (Karlsruhe, Germany), Serva (Heidelberg, Germany), Seikagaku 
Corporation (Tokyo, Japan), Sigma-Aldrich (St. Louis, USA), Thermo Fisher 
Scientific (Waltham, USA) and VWR (Radnor, USA). Restriction endonucleases and 
deoxynucleotide triphosphates (dNTPs) were from New England Biolabs (Ipswitch, 
USA). DNA polymerases were obtained from Agilent Technologies (Santa Clara, 
USA), New England Biolabs and Thermo Fisher Scientific and alkaline phosphatases 
were from Roche Life Science (Penzberg, Germany) and Thermo Fisher Scientific. 
Custom-made DNA oligonucleotides for PCR applications were from Eurofins 
Genomics (Ebersberg, Germany). 
 
5.1 Microbiological methods 
5.1.1 Escherichia coli (E. coli) techniques 
 
E. coli strains 
Name Genotype Source 
XL1-blue 
 
Rosetta 
recA1 andA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZΔM15 Tn10 (Tetr)] 
F- ompT hsdSB(rB- mB-) gal dcm pRARE (CamR) 
Agilent 
 
Merck Millipore 
 
E. coli plasmids 
Plasmid constructs encoding GST fusion proteins were based on the vector pGEX-
4T-1 (GE Healthcare, Chicago, USA). For the expression of GST-Ssa1, the full-
length SSA1 open reading frame was amplified by PCR using yeast genomic DNA 
(DF5 background) as template and cloned into pGEX-4T-1. 
 
Media, buffers and solutions 
 
LB medium (plates)  1 % tryptone 
    0.5 % yeast extract 
    1 % NaCl 
    (1.5 % agar) 
    sterilized by autoclaving 
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TFB-I    30 mM KOAc 
    50 mM MnCl2 
    100 mM KCl 
    15 % glycerol 
    pH 5.8 (adjusted with HOAc) 
 
TFB-II    10 mM MOPS 
    7.5 mM CaCl2 
    10 mM KCl 
    pH 7 (adjusted with NaOH) 
 
Cultivation and storage of E. coli cells 
E. coli cells harboring plasmids were grown overnight at 37°C on LB agar plates 
containing appropriate antibiotics (100 µg/ml ampicillin or 30 µg/ml kanamycin). 
Plates were sealed with parafilm and stored at 4°C for up to one week. For long-term 
storage, stationary cultures were frozen as glycerol stocks containing 15 % (v/v) 
glycerol and stored at -80°C. Liquid cultures containing appropriate antibiotics 
(100 µg/ml ampicillin or 30 µg/ml kanamycin) were usually inoculated from single 
colonies and grown at 37°C with constant shaking. For protein expression, liquid 
cultures were shifted to 25°C. 
Preparation of competent E. coli cells 
For the preparation of competent E. coli cells, 200 ml LB medium were inoculated 
with 1 ml of a fresh overnight culture grown at 37°C. The main culture was grown at 
37°C until an OD600 of 0.45-0.55 was reached. The flasks were then chilled on ice for 
10 min and the cells were harvested by centrifugation (5000 g, 10 min, 4°C). 
Subsequently, the supernatant was removed and the cell pellet was resuspended in 
30 ml TFB-I solution. After further incubation on ice for 10 min, the bacteria were 
pelleted by centrifugation and resuspended in 6 ml TFB-II solution. Competent E. coli 
cells were frozen as 100 µl aliquots on dry ice and stored at -80°C. 
Transformation of E. coli cells 
Chemically competent E. coli cells were thawed on ice and 50 µl cells were mixed 
with an appropriate amount of plasmid DNA or 2 µl of a ligation sample. After 
incubation on ice for 20-30 min, the cells were heat-shocked at 42°C for 45 s. The 
reaction tubes were then cooled on ice for 2 min and 300 µl LB medium were added 
followed by recovery at 37°C for 20 min. Subsequently, the cells were plated on LB 
agar plates containing an appropriate antibiotic and transformants were grown 
overnight at 37°C. 
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Recombinant protein expression 
Expression of recombinant GST fusion proteins was performed using Rosetta E. coli 
cells. Chemically competent cells were transformed with pGEX-4T-1-based 
expression vectors carrying the gene of interest and transformants were selected for 
on LB agar plates containing ampicillin following overnight growth. To start growth in 
liquid cultures, 25 ml LB medium were inoculated with a single colony and grown 
overnight at 37°C. The next day, precultures were diluted 1:100 with fresh LB 
medium and the cells were grown at 37°C until an OD600 of 0.5 was reached. The 
cultures were then cooled down to 25°C and protein expression was induced by 
addition of 1 mM IPTG. The cultures were further incubated over night with shaking 
and cells were harvested by centrifugation (10 min, 5000 g, 4°C). If required, cell 
pellets were frozen in liquid N2 and stored at -80°C. 
 
5.1.2 Saccharomyces cerevisiae (S. cerevisiae) techniques 
 
S. cerevisiae strains 
Name Genotype Source 
DF5 
W303 
 
Y0002 
Y2725 
JN516 
ssa1-45 
CMY826 
 
CMY763 
YFP162 
YFP140 
YFP141 
YFP167 
 
YFP154 
 
YFP155 
 
YFP171 
 
YFP156 
 
YFP157 
his3-Δ200, leu2-3, 2-112, lys2-801, trp1-1, ura3-52 
leu2-3,112, ade2-1, can1-100, his3-11,15, ura3-1, 
trp1-1, RAD5 
DF5, Matα 
W303, Matα 
Matα, SSA1 Δssa2::LEU2 Δssa3::TRP1 Δssa4::LYS2 
Matα, ssa1-45 Δssa2::LEU2 Δssa3::TRP1 Δssa4::LYS2 
Mata, ura3-52, leu2Δ1, his3Δ-200, trp1Δ63, lys2-801, ade2-101, 
Δbar1::HIS3 
Matα, cim3-1, ura3-52, leu2Δ1 
CMY826, Mata, YIplac211-pADH-HisSMT3::URA3 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 (cl.1) 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 (cl. 2) 
CMY826, Mata, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 (cl. 1) 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 (cl. 2) 
CMY826, Mata, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 (cl. 1) 
CMY763, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 (cl. 2) 
D. Finley 
X.Zhao 
 
D. Finley 
X. Zhao 
E. Craig 
E. Craig 
C. Mann 
 
C. Mann 
this study 
this study 
this study 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
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Name Genotype Source 
YFP516 
YFP519 
YFP602 
 
YFP606 
 
YFP612 
 
YFP616 
 
YFP594 
 
YFPX4-3A 
YFPX244-5C 
 
YFPX245-7C 
 
YFPX248-2C 
 
YFPX10-5C 
YFPX103-3D 
YFPX12-9B 
YFPX112-16D 
YFPX14-1C 
 
YFPX115-11A 
 
YFPX149-12D 
 
YFPX147-4B 
 
YFPX153-2D 
 
YFPX16-6C 
 
YFPX16-2D 
 
YFPX116-3B 
 
YFPX150-7C 
 
YFPX164-3C 
 
YFPX165-14B 
 
YFPX71-2A 
 
YFPX246-12A 
JN516, Matα, YIplac211-pADH-HisSMT3::URA3 
ssa1-45, Matα, YIplac211-pADH-HisSMT3::URA3 
JN516, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 
JN516, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 
ssa1-45, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 
ssa1-45, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 Δzip3::hphNT1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
Δsiz1::hphNT1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
Δsiz2::natNT2 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
Δsiz1::hphNT1 Δsiz2::natNT2 
DF5, Matα, ADH33HA::kanMX4 
DF5, Matα, ADH33HA::TRP1 
DF5, Matα, ILV63HA::kanMX4 
DF5, Matα, ILV63HA::TRP1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::TRP1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 Δsiz1::hphNT1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 Δsiz2::HIS3MX6 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ADH33HA::kanMX4 Δsiz1::hphNT1 Δsiz2::HIS3MX6 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 
DF5, Mata, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::TRP1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 Δsiz1::hphNT1 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 Δsiz2::natNT2 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 Δsiz1::hphNT1 Δsiz2::natNT2 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 mms21-11::natNT2 
DF5, Matα, YIplac211-pADH-HisSMT3::URA3 
ILV63HA::kanMX4 cim3-1 
this study 
this study 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
this study 
 
this study 
 
this study 
 
this study 
this study 
this study 
this study 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
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Name Genotype Source 
YFPX266-20C 
 
YFP339 
YFPX212-7D 
 
YFPX213-7D 
 
YFP627 
YFP630 
YFPX251-15C 
 
YFPX256-9C 
 
YFPX255-3B 
 
YFPX254-6D 
 
YFPX255-7D 
 
YFPX259-2D 
 
YFPX260-7C 
 
YFPX205-3B 
 
YFPX206-13B 
 
YFPX283-4A 
 
YFPX284-3D 
 
YFPX288-3D 
 
YFPX292-7C 
DF5, Matα, pADH-GFPSMT3::natNT2 
ILV63HA::kanMX4 cim3-1 
W303, Matα, YIplac211-pADH-HisSMT3::URA3 
W303, Matα, YIplac211-pADH-HisSMT3::URA3 
Δsiz1::hphNT1 
W303, Matα, YIplac211-pADH-HisSMT3::URA3 
Δsiz2::natNT2 
W303, Matα, pRS306-pGAL-ADH33HA-tCYC1::URA3 
W303, Matα, pRS306-pGAL-adh328-3753HA-tCYC1::URA3 
W303, Matα, YIplac128-pADH-HisSMT3::LEU2 
pRS306-pGAL-ADH33HA-tCYC1::URA3 
W303, Matα, YIplac128-pADH-HisSMT3::LEU2 
pRS306-pGAL-adh328-3753HA-tCYC1::URA3 
W303, Matα, YIplac128-pADH-HisSMT3::LEU2 
pRS306-pGAL-adh328-3753HA-K305R-tCYC1::URA3 
W303, Matα, YIplac128-pADH-HisSMT3::LEU2 
pRS306-pGAL-adh328-3753HA-tCYC1::URA3 cim3-1 
W303, Matα, YIplac128-pADH-HisSMT3::LEU2 
pRS306-pGAL-adh328-3753HA-K305R-tCYC1::URA3 cim3-1 
W303, Matα, YIplac211-pGAL-HisSMT3GG::URA3 
ILV63HA::TRP1 
W303, Matα, YIplac211-pGAL-HisSMT3GG-Q95P::URA3 
ILV63HA::TRP1 
W303, Matα, YIplac211-pGAL-HisSMT3GG::URA3 
ILV63HA::TRP1 cim3-1 
W303, Matα, YIplac211-pGAL-HisSMT3GG-Q95P::URA3 
ILV63HA::TRP1 cim3-1 
W303, Matα, YIplac211-pGAL-HisSMT3GG::URA3 
ILV63HA::TRP1 Δslx5::natNT2 Δslx8::HIS3MX6 
W303, Matα, YIplac211-pGAL-HisSMT3GG-Q95P::URA3 
ILV63HA::TRP1 Δslx5::natNT2 Δslx8::HIS3MX6 
W303, Matα, YIplac211-pGAL-HisSMT3GG::URA3 
ILV63HA::TRP1 Δris1::natNT2 
W303, Matα, YIplac211-pGAL-HisSMT3GG-Q95P::URA3 
ILV63HA::TRP1 Δris1::natNT2 
this study 
 
this study 
this study 
 
this study 
 
this study 
this study 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
this study 
 
S. cerevisiae vectors 
Name Plasmid type Source 
YIplac128 
YIplac211 integrative Gietz and Sugino, 1988 
pRS306 integrative Sikorski and Hieter, 1989 
YCplac22 centromeric Gietz and Sugino, 1988 
p413ADH 
p415ADH 
p415GAL 
 
centromeric 
 
Mumberg et al., 1994, 1995 
pRS306-pGAL integrative this study 
p413TDH3 centromeric this study 
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S. cerevisiae plasmids 
Plasmids for the expression of HisSUMO under control of the ADH1 promoter were 
based on the integrative vectors YIplac211 and YIplac128 (Gietz and Sugino, 1988), 
respectively and have been described previously (Hoege et al., 2002; Psakhye and 
Jentsch, 2012; Sacher et al., 2006). ORFs encoding mature HisSUMO variants (wild 
type and Q95P) were cloned into YIplac211 under control of the GAL1 promoter. 
 For subsequent cloning into different types of expression vectors, ORFs 
encoding C-terminally 3HA-tagged proteins (and N-terminally truncated mutant 
variants) were amplified by PCR using specific primer pairs. The respective template 
DNA was isolated from yeast cells, in which individual genes were chromosomally 
fused to cassettes encoding C-terminal 3HA epitopes. These ORFs were then cloned 
into vectors of the p41XADH or p41XGAL series (Mumberg et al., 1994, 1995) for 
expression under control of the ADH1 and GAL1 promoter, respectively. For the 
expression of wild type Ilv63HA and various KR mutant variants under control of the 
endogenous promoter, the ILV6 promoter, the ILV63HA ORF and the ILV6 terminator 
were cloned into YCplac22 (Gietz and Sugino, 1988). 
 For expression of wild type Adh33HA and Δmts-adh33HA from the GAL1 or the 
TDH3 promoter, the respective ORFs were cloned into p415GAL, pRS306-pGAL or 
p413TDH3. pRS306-pGAL was generated by subcloning a DNA fragment comprising 
the GAL1 promoter, the multiple cloning site and the CYC1 terminator from p415GAL 
into pRS306 (Sikorski and Hieter, 1989). For the generation of p413TDH3, the GAL1 
promoter of p413GAL was replaced by the TDH3 promoter. 
 In all constructs, KR mutations were introduced by site-directed mutagenesis 
using specific primer pairs. 
 
Media, buffers and solutions 
 
YPD/YPGal (plates)  1 % yeast extract 
    2 % bacto peptone 
    2 % D-glucose/D-galactose 
    (2 % agar) 
    sterilized by autoclaving 
 
YPD selection plates  YPD agar was autoclaved, cooled down to 50°C and
    the respective antibiotic was added: 
geneticin (G418 sulfate, Thermo Fisher Scientific) 
    to 200 mg/l 
    nourseothricin (NAT, HKI, Jena) to 100 mg/l 
    hygromycin (Hygro, Cayman Chemical) to 500 mg/l 
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SC-media (plates)  0.67 % yeast nitrogen base 
    0.2 % amino acid drop-out mix (lacking one or multiple 
    compounds if required) 
    2 % carbon source (D-glucose, D-raffinose or 
    D-galactose) 
 
Amino acid drop-out mix 4.0 g Leu 
    2.0 g Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, 
     Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, Val 
    2.0 g myo-inositol 
    2.0 g uracil 
    0.5 g adenine 
    0.2 g p-aminobenzoic acid 
 
SORB solution  100 mM LiOAc 
    10 mM Tris-HCl pH 8.0 
    1 mM EDTA pH 8.0 
    1 M sorbitol 
    sterilized by filtration 
 
PEG solution   100 mM LiOAc 
    10 mM Tris-HCl pH 8.0 
    1 mM EDTA pH 8.0 
    40 % (w/v) PEG-3350 
    sterilized by filtration 
    stored at 4°C 
 
Sporulation medium  2 % (w/v) KOAc 
    sterilized by autoclaving 
 
Sporulation plates  0.25 % yeast extract 
    0.1 % D-glucose 
    2 % KOAc 
    0.168 % CSM powder 
    2 % agar 
    adjusted to pH 7 with KOH/HOAc 
 
Zymolyase solution  0.9 M sorbitol 
    0.1 M Tris-HCl pH 8.0 
    0.2 M EDTA pH 8.0 
    50 mM DTT 
    0.5 mg/ml Zymolyase-100T (Seikagaku Corporation) 
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Cultivation and storage of S. cerevisiae cells 
S. cerevisiae cells were grown on agar plates and in liquid cultures, respectively. For 
growth on plates, yeast cells were streaked from glycerol stocks using a sterile 2 ml 
glass pipette and incubated at 30°C for 2-3 days. Plates with temperature-sensitive 
strains were kept at the permissive temperature (typically 25°C) for 3-4 days. 
 Liquid cultures were inoculated with cells from freshly streaked agar plates 
and grown overnight at 25°C or 30°C on a shaking platform. Main cultures were 
obtained by diluting fresh overnight cultures to an OD600 of 0.1-0.2. These cultures 
were incubated in baffle-flasks (flask volume ≥ 5x liquid culture volume) with constant 
shaking at 110-150 rpm until the mid log growth phase was reached (OD600 = 0.6-
1.0). Notably, all hypomorphic mutants (cim3-1 and ssa1-45) used in this study were 
grown at 25°C. A temperature shift to 37°C is not required for these strains. Culture 
densities (OD600) were determined photometrically and yeast cells were harvested by 
centrifugation. Yeast cultures on agar plates were sealed with parafilm and stored at 
4°C for 1-4 weeks. For long-term storage, stationary cultures were frozen as glycerol 
stocks containing 15 % (v/v) glycerol and stored at -80°C. 
Preparation of competent S. cerevisiae cells 
Yeast cells from a fresh overnight culture were inoculated in 50 ml medium (usually 
YPD) to an OD600 of 0.1-0.2 and grown until an OD600 of 0.5-0.7 was reached. The 
cells were harvested by centrifugation (500 g, 5 min, room temperature), washed first 
with 25 ml sterile dH2O and subsequently with 5 ml sterile SORB solution. The cell 
pellet was then resuspended in 360 µl SORB solution, mixed with 40 µl carrier DNA 
(10 mg/ml salmon or herring sperm DNA, Thermo Fisher Scientific) and stored 
at -80°C. 
Transformation of S. cerevisiae cells 
For transformation, 200 ng of circular plasmid DNA and 2 µg of linear DNA 
(linearized plasmid DNA or PCR products) were added to 10 µl and 50 µl of 
competent yeast cells, respectively. The cells were mixed with 6 volumes of PEG 
solution and incubated at room temperature for 30 min. After addition of 10 % sterile 
DMSO the cells were heat-shocked at 42°C for 8-15 min and pelleted by 
centrifugation (500 g, 3 min, room temperature). For the selection of transformants 
containing auxotrophic markers, cells were resuspended in 100 µl sterile dH2O and 
directly plated on the respective SC agar plates. For the selection of transformants 
on plates containing antibiotics, cells were resuspended 700 µl YPD and incubated at 
30°C (25°C for temperature-sensitive strains) for 3-4 h prior to plating. Stable 
transformants were grown at 30°C (25°C for temperature-sensitive strains) for 2-4 
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days. If required, replica plating using sterile velvet was performed to remove 
background. 
Genetic manipulation of S. cerevisiae 
S. cerevisiae is a highly recombination-proficient organism and therefore ideally 
suited for genetic manipulation. Gene deletion mutants and chromosomally tagged 
strains were constructed using a PCR-based strategy (Janke et al., 2004; Knop et 
al., 1999). In brief, targeting cassettes containing selection markers (and optionally 
sequences encoding epitope tags) were generated by PCR and transformed into 
competent yeast cells. Upon integration of the cassettes into the yeast genome, 
stable transformants were selected on appropriate agar plates. Subsequently, 
integration of deletion constructs at the correct genomic locations was verified by 
yeast colony PCR using specific primer pairs. In case of epitope taggings, expression 
of the respective fusion proteins was additionally confirmed by western blot analysis 
using epitope-specific antibodies. 
 Integrative yeast plasmids (based on the vectors YIplac128, YIplac211 and 
pRS306) were linearized by treatment with restriction endonucleases. Selected cut 
sites were located within inserts (BglII for the YIplac211-pADH-HisSMT3 construct) 
and marker genes (EcoRV for LEU2 in the YIplac128-pADH-HisSMT3 construct and 
NcoI for URA3 in pRS306-based constructs), respectively. Linearized plasmids were 
then transformed into competent yeast cells and stable transformants were selected 
on appropriate agar plates. Plasmid integration at the correct chromosomal loci was 
verified by yeast colony PCR and expression of encoded proteins was confirmed by 
western blot analysis. 
Mating of haploid S. cerevisiae strains 
For mating of haploid yeast strains, freshly streaked cells of opposite mating type 
(Mat a and Mat α) were mixed on a YPD plate using sterile toothpicks. The plate was 
then incubated over night at 30°C (25°C for temperature-sensitive strains) and diploid 
cells were identified by growth on double selection plates. In cases, for which the use 
of double selection plates was not applicable, diploid cells were identified by 
consecutive streaking on different selection plates. 
Sporulation and tetrad analysis of diploid S. cerevisiae strains 
For sporulation in liquid medium, diploid yeast cells from 500 µl of a saturated 
overnight culture (typically grown in YPD at 30°C) were harvested by centrifugation 
(500 g, 3 min, room temperature). The cells were washed three times with 1 ml 
sterile dH2O and once with sporulation medium. Subsequently, the cells were 
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resuspended in 4 ml sporulation medium and incubated at room temperature on a 
shaker for 3-6 days. Prior to tetrad dissection, 10 µl of a sporulated culture were 
mixed with 10 µl zymolyase solution and incubated at room temperature for 5 min. 
The cells were then transferred to a YPD agar plate, dried and tetrad dissection was 
performed using a MSM400 micromanipulator (Singer Instruments, Roadwater, UK). 
 For sporulation on plate, diploid cells were streaked on a sporulation plate 
and incubated at 30°C (25°C for temperature-sensitive strains) for 3-4 days. A patch 
of cells from a sporulation plate was resuspended in 1 ml sterile dH2O and 10 µl of 
the suspension was mixed with 10 µl zymolyase solution. After incubation for 5 min 
at room temperature the cells were transferred to a YPD agar plate and tetrad 
dissection was performed as described above. 
 Tetrads were grown at 30°C (25°C for temperature-sensitive strains) for 2-3 
days and genotypic analysis was performed by replica plating on selection plates. 
Temperature-sensitive spores were identified by replica plating on YPD plates and 
incubation at the non-permissive temperature (typically 37°C). 
Mating type analysis 
Mating types of haploid yeast cells were analyzed using the tester strains RC634a 
and RC75-7α (Dietzel and Kurjan, 1987). These strains display a strong sensitivity 
towards mating pheromones secreted by cells of the opposite mating type. To 
generate tester plates for mating type analysis, patches of freshly streaked tester 
cells were resuspended in 1 % agar (cooled to max. 40°C) and poured onto YPD 
plates. Tetrads were replica plated onto tester plates and incubated at 30°C (25°C for 
temperature-sensitive strains) for 1-2 days. Growth inhibition of the tester strain in 
the top layer agar in close proximity to cells of the opposite mating type leads to 
formation of a so called “halo” and thereby allows the determination of the 
corresponding mating type. Diploid cells do not secrete mating type pheromones and 
can be identified by the absence of a ‘halo’ on both types of tester plates. 
Spotting assays 
Spotting assays were used to analyze the growth phenotypes of yeast strains at 
different temperatures. Cells grown in liquid cultures were diluted to an OD600 of 1 
and six 5-fold serial dilutions in sterile dH2O were prepared. These dilutions were 
spotted on agar plates using a custom-made stamping device followed by incubation 
at different temperatures for 2-5 days. 
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5.2 Methods in molecular biology 
 
General buffers and solutions 
 
TBE buffer   90 mM Tris 
    90 mM boric acid 
    2.5 mM EDTA 
 
10x DNA sample buffer 0.25 % bromophenol blue 
    0.25 % xylene cyanol FF 
    50 % glycerol 
 
5.2.1 Nucleic acid purification and analysis 
Isolation of plasmid DNA from E. coli cells 
Isolation of plasmid DNA from E. coli cells was performed with the AccuPrep Plasmid 
Mini Extraction Kit (Bioneer Corporation, Daejeon, South Korea) and the QIAGEN 
Plasmid Mini Kit (Qiagen, Hilden, Germany), respectively. 5 ml LB medium 
containing 100 µg/ml ampicillin or 30 µg/ml kanamycin were inoculated with a single 
E. coli colony and grown over night at 37°C. Cells were pelleted by centrifugation and 
plasmid isolation was performed according to the manufacturers’ instructions. 
Purification of genomic DNA from S. cerevisiae cells 
Purification of genomic DNA from yeast cells was performed using the MasterPure 
Yeast DNA Purification Kit (Epicentre, Madison, USA) according to the 
manufacturer’s instructions. Typically, cells from 500 µl of a fresh overnight culture 
were used. 
Purification of PCR products 
Linear DNA fragments generated by PCR were purified using the QIAquick PCR 
Purification Kit (Qiagen) and the AccuPrep PCR Purification Kit (Bioneer 
Corporation), respectively. Both kits were used according to the manufacturers’ 
instructions. 
Agarose gel electrophoresis of DNA molecules 
DNA fragments generated by PCR or by digestion of plasmid DNA using restriction 
endonucleases were resolved using agarose gel electrophoresis. Gels were 
prepared by dissolving 1-2 % agarose in TBE buffer in a microwave. 
Ethidiumbromide was added to a final concentration of 0.5 µg/ml and the solution 
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was poured into a gel casting form. Before loading, DNA samples were mixed with 
an appropriate volume of 10x DNA sample buffer. Electrophoretic separation was 
carried out in TBE buffer at a constant voltage of 80-120 V. DNA bands were 
visualized by UV illumination. 
Extraction of DNA fragments from agarose gels 
For the isolation of DNA from agarose gels, the required fragment was visualized by 
ethidium bromide staining and excised from the gel on a UV transilluminator using a 
clean razor blade. The gel block was transferred to a sterile 1.5 ml reaction tube and 
the DNA was purified using the QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions. 
Determination of DNA concentrations 
Concentrations of DNA in aqueous solutions were determined photometrically using 
a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). Measurements 
were based on the following calculation: 
 
1 A260 unit of dsDNA ≈ 50 µg/ml in dH2O 
 
The purity of DNA solutions was estimated by the following value: 
 
A260 / A280 ≥ 1.8 
DNA sequence analysis 
DNA sequencing was performed by at the MPIB microchemistry core facility using an 
ABI 3730 DNA analyzer (Applied Biosystems/Thermo Fisher Scientific) and the ABI 
Big Dye 3.1 sequencing system. Alternatively, DNA samples were sent to Eurofins 
Genomics for custom DNA sequencing. 
 
5.2.2 DNA amplification by polymerase chain reaction (PCR) 
Amplification of DNA fragments for molecular cloning 
For molecular cloning, DNA fragments were amplified using Phusion high fidelity 
DNA polymerase (Thermo Fisher Scientific). Primers with restriction sites within the 
5’-overhangs were designed to consist of 20-23 nucleotides complementary to the 
DNA sequence of interest. PCR reactions were set up on ice in a total volume of 
50 µl. 
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PCR reaction mix: 5.0 µl 5x Phusion HF buffer 
   1.0 µl genomic DNA 
   2.5 µl primer 1 (10 µM) 
   2.5 µl primer 2 (10 µM) 
   1.0 µl dNTP mix (10 mM each) 
   0.5 µl Phusion High-Fidelity DNA polymerase 
   31.5 µl dH2O 
 
Thermocycler program (34 amplification cycles): 
 
PCR step T [°C] Time 
Initial denaturation 98 30 s 
Denaturation 98 10 s 
Annealing 50-55 30 s 
Elongation 72 15-30 s/kb 
Final elongation 72 10 min 
Cooling 4 ∞ 
 
Amplification of yeast targeting cassettes 
Targeting cassettes for gene deletions and chromosomal epitope taggings in yeast 
were amplified using a mixture of Taq (purified by U. Cramer, Department of 
Molecular Cell Biology, MPIB) and Vent DNA polymerases (Thermo Fisher 
Scientific). The PCR cycling parameters have been described previously (Janke et 
al., 2004). Primers were designed in a way that the resulting PCR products 
containing the selection marker (and optionally a sequence encoding the epitope tag) 
were flanked by 55 bp-long targeting arms on both sides. The sequences of these 
targeting arms were homologous to the genomic loci of interest. PCR reactions were 
set up on ice in a total volume of 50 µl. 
 
PCR reaction mix: 5.0 µl 10x ThermoPol reaction buffer 
   2.0 µl plasmid DNA (app. 50 ng/µl) 
   3.2 µl primer 1 (10 µM) 
   3.2 µl primer 2 (10 µM) 
   1.75 µl dNTP mix (10 mM each) 
   0.4 µl Taq DNA polymerase 
   0.2 µl Vent DNA polymerase 
   34.25 µl dH2O 
 
Verification of genomic recombination events (yeast colony PCR) 
The integration of plasmids or targeting cassettes at the correct genomic loci was 
confirmed by yeast colony PCR using the Whole Cell Yeast PCR Kit (MP 
Biomedicals) according to the manufacturer’s instructions. In brief, a small portion of 
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a single yeast colony was resuspended in 2.5 µl lysis solution using a sterile pipette 
and lysed by incubation for 1h at 37°C. Subsequently, the lysate was mixed with 
22.5 µl PCR master mix and the reaction tubes were transferred into a PCR thermo 
cycler. 
 
PCR reaction mix: 5.0 µl 10x ThermoPol reaction buffer 
   2.5 µl genomic DNA (cell extract) 
   5.0 µl primer 1 (10 µM) 
   5.0 µl primer 2 (10 µM) 
   1.75 µl dNTP mix (10 mM each) 
   1.25 µl Taq DNA polymerase 
   29.5 µl dH2O 
 
Thermocycler program (40 amplification cycles): 
 
PCR step T [°C] Time 
Initial denaturation 94 3 min 
Denaturation 94 30 s 
Annealing 50 30 s 
Elongation 72  2 min 
Final elongation 72 10 min 
Cooling 4 ∞ 
 
Site-directed mutagenesis 
PCR-based site-directed mutagenesis related to the QuickChange method 
(Stratagene/Agilent Technologies) was used to introduce specific mutations, 
insertions or deletions into plasmid DNA. The approach requires two complementary 
primers, which consist of one or multiple central nucleotides harboring the desired 
mutation(s), flanked by 15 nucleotides of the correct target sequence on both sides. 
Dam-methylated circular plasmid DNA served as template for the PCR reaction and 
PCR amplification was performed using PfuTurbo DNA polymerase (Agilent 
Technologies) in a total volume of 25 µl. 
 
PCR reaction mix: 2.5 µl 10x Cloned Pfu DNA polymerase reaction buffer 
   0.5 µl template DNA (app. 500 ng/µl) 
   0.5 µl primer 1 (10 µM) 
   0.5 µl primer 2 (10 µM) 
   0.6 µl dNTP mix (10 mM each) 
   0.5 µl PfuTurbo DNA polymerase 
   19.9 µl dH2O 
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Thermocycler program (19 amplification cycles): 
 
PCR step T [°C] Time 
Initial denaturation 94 3 min 
Denaturation 94 30 s 
Annealing 49 45 s 
Elongation 68 16 min 
Final elongation 68 16 min 
Cooling 4 ∞ 
 
Subsequent to PCR, the methylated template DNA was selectively digested by DpnI 
treatment for 3-4 h at 37°C. The resulting PCR product was transformed into 
competent E. coli cells and plasmid DNA was isolated from several individual clones. 
Plasmids harboring the desired mutation(s) were identified by DNA sequencing. 
 
5.2.3 Molecular cloning 
Cleavage of DNA with restriction endonucleases 
Restriction endonucleases (New England Biolabs) were used for the sequence-
specific cleavage of DNA molecules. For analytical purposes, app. 1 µg of circular 
plasmid DNA isolated from E. coli was incubated with the respective restriction 
endonucleases for 1-3h at 37°C. For molecular cloning, vector DNA and DNA 
fragments obtained by PCR were usually digested over night at 37°C. 
Dephosphorylation of vector DNA 
To prevent the religation of vector DNA during ligation reactions, 5’ end 
dephosphorylation was performed using FastAP (Thermo Fisher Scientific) and rAPid 
Alkaline Phosphatase (Roche), respectively. 2 µl phosphatase were mixed directly 
with the restriction digest and incubated at 37°C for 2-4h. Subsequently, the 
linearized vector DNA was purified using agarose gel electrophoresis followed by gel 
extraction. 
Ligation of DNA fragments 
Ligation of DNA fragments with linearized (dephosphorylated) vector DNA was 
performed using T4 DNA ligase and the Quick DNA Ligation Kit (New England 
Biolabs), respectively. Typically, vector DNA and inserts were mixed in a 1:3 molar 
ratio. Ligation reactions using Quick T4 DNA ligase were incubated at 25°C for 5 min. 
Ligation reactions using T4 DNA ligase were incubated at 25°C for 10 min or 
overnight at 16°C. Subsequently, the reaction tubes were chilled on ice and 
transformed into competent E. coli cells. 
MATERIALS AND METHODS 
 
 82 
5.3 Biochemical and cell biological methods 
 
General buffers and solutions 
 
HU sample buffer  8 M urea 
    5 % SDS 
    1 mM EDTA 
    1.5 % DTT 
    0.025 % bromophenolblue 
    200 mM Tris-HCl pH 6.8 
 
MOPS running buffer  50 mM MOPS 
    50 mM Tris base 
    3.5 mM SDS 
    1 mM EDTA 
 
Transfer buffer  250 mM Tris base 
    1.92 M glycine 
    0.1 % SDS 
    20 % (v/v) methanol 
 
TBST    25 mM Tris-HCl pH 7.5 
    137 mM NaCl 
    2.6 mM KCl 
    0.1 % Tween 20 
 
PBS    137 mM NaCl 
    2.7 mM KCl 
    4.3 mM Na2HPO4 
    1.47 mM KH2PO4 
    pH 7.5 
 
Blocking solution  5 % (w/v) skim milk powder in TBST 
 
5.3.1 Protein methods 
Preparation of total cell extracts by trichloroacetic acid (TCA) precipitation 
Trichloroacetic acid (TCA) precipitation was used for the preparation of small-scale 
denatured total protein extracts from yeast cells. Typically, 1 OD of cells were 
resuspended in 1 ml ice-cold dH2O and lysed by addition of 150 µl 1.85 M 
NaOH/7.5 % β-mercaptoethanol. After 15 min incubation on ice, proteins were 
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precipitated by addition of 150 µl 55 % TCA and further incubation on ice for 10 min. 
The denatured material was recovered by two sequential centrifugation steps 
(14 krpm, 10 min, 4°C) and aspiration of the supernatant. Subsequently, the pellet 
was resuspended in 100 µl HU sample buffer by vigorous agitation for 10 min at 
65°C. 
Purification of HisSUMO conjugates from denatured yeast extracts 
Purification of HisSUMO conjugates from yeast was performed by Ni-NTA pull-downs 
under denaturing conditions (Hoege et al., 2002; Sacher et al., 2006). Typically, 
200 OD of yeast cells from logarithmically growing cultures were harvested by 
centrifugation (2500 g, 5 min, 4°C), washed once with ice-cold dH2O and flash-frozen 
in liquid N2. Optionally, cell pellets were stored at -80°C. Yeast cells were then lysed 
by resuspending the pellets in 6 ml 1.85 M NaOH containing 7.5 % β-
mercaptoethanol and incubation on ice for 15 min. Subsequently, the cellular 
material was precipitated by addition of 6 ml 55 % TCA and further incubation on ice 
for 15 min. The precipitated material was pelleted by centrifugation (3000 g, 30 min, 
4°C), washed twice with 50 ml ice-cold dH2O and solubilized in 12 ml buffer A (6 M 
guanidinium hydrochloride, 100 mM NaH2PO4, 10 mM Tris-HCl, pH 8) containing 
0.05 % Tween-20. The samples were incubated on a shaking platform for 1-2h 
(220 rpm, RT) and insoluble material was removed by centrifugation (23,000 g, 
20 min, 4°C). The supernatants were transferred to 15 ml Falcon tubes, mixed with 
imidazole to a final concentration of 20 mM and 50-100 µl of magnetic Ni-NTA 
agarose beads (Qiagen) were added. After overnight incubation at 4°C on a tube 
roller, the beads were recovered by centrifugation (1000 rpm, 5 min, 4°C), 
transferred to 1.5 ml reaction tubes and washed three times with buffer A containing 
20 mM imidazole/0.05 % Tween-20 and five times with buffer C (8 M urea, 100 mM 
NaH2PO4, 10 mM Tris-HCl, pH 6.3) containing 0.05 % Tween-20. To remove 
detergents, the beads were then transferred to a fresh 1.5 ml reaction tube using 
100 µl buffer C without Tween-20. Eventually, proteins bound to the beads were 
eluted by shaking in 30 µl 1 % SDS for 10 min at 65°C. The samples were dried in a 
SpeedVac centrifuge (Eppendorf, Hamburg, Germany) at 45°C for 30 min, dissolved 
in 10 µl dH2O and 15 µl HU buffer for 10 min at 65°C and analyzed by SDS-PAGE 
and western blotting. 
Preparation of native yeast cell lysates and cellular fractionation 
For the preparation of native cell lysates from yeast, usually 100-200 OD of yeast 
cells were harvested by centrifugation (2000 g, 5 min, 4°C), washed once with ice-
cold PBS and resuspended in 700 µl ice-cold lysis buffer in a 2 ml reaction tube. 
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Zirconia/silica beads (BioSpec Inc., Bartlesville, USA) were added until a 2 mm liquid 
phase was visible on top of the beads. Cells were then lysed at 4°C in a MM301 
multi-tube bead-beater (Retsch Technology, Haan, Germany) using 6 disruption 
intervals of 1 min (frequency = 30 Hz), each followed by 5 min incubation on ice. The 
piggyback method was used to separate cellular lysates from beads and to transfer 
the lysates into fresh 15 ml Falcon tubes. 
 Cellular fractionations assessing the solubility of proteins were performed as 
described previously (Fang et al., 2011). In brief, yeast cells were lysed by bead-
beating in lysis buffer (100 mM HEPES pH 7.5, 1 % Triton X-100, 300mM NaCl, 1x 
complete EDTA-free protease inhibitor cocktail (Roche), 1 mg/ml Pefabloc SC 
(Roche)). Subsequently, the lysates were pre-cleared by centrifugation (2000 g, 
10 min, 4°C) and the resulting total cell extracts (T fraction) were fractionated by a 
second centrifugation step (16000 g, 10 min, 4°C) to yield soluble (S) and insoluble 
pellet (P) fractions. 10 µl of each, the total and soluble fractions, were mixed with 
50 µl HU sample buffer and denatured at 65°C for 10 min in a thermo shaker. The 
pellet was washed three times with 1 ml ice cold lysis buffer and resolubilized in 50 µl 
HU sample buffer at 65°C for 10 min. 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Size-dependent separation of proteins by denaturing SDS polyacrylamide gel 
electrophoresis was performed using pre-cast 12 % or 4-12 % NuPAGE Novex Bis-
Tris gels (Thermo Fisher Scientific). Protein samples were prepared in HU buffer and 
denatured by shaking for 10 min at 65°C. Electrophoretic separation was carried out 
in MOPS running buffer at a constant voltage of 110-140V. The All Blue Precision 
Plus pre-stained protein standard (Bio-Rad Laboratories) served as molecular weight 
marker. 
Western blot analysis 
Western blotting was performed using a wet tank blotting system (Hoefer Inc. 
Holliston, USA). Proteins from polyacrylamide gels were transferred to Immobilon-P 
PVDF membranes (Merck Millipore) in fresh transfer buffer at a constant voltage of 
75 V for 90 min. Subsequently, the membranes were briefly washed in TBST and 
blocked by shaking in blocking solution for 60 min. Incubation with primary antibodies 
diluted in blocking solution containing 0.05 % sodium azide was performed over night 
at 4°C. The next day, the membranes were washed four times for 5 min with TBST 
and incubated with specific horseradish peroxidase (HRP)-coupled secondary 
antibodies (Dianova, Hamburg, Germany) in blocking solution at room temperature 
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for 1-3 h. The membranes were washed four times for 10 min with TBST and protein 
detection was performed using the ECL or ECL Plus chemiluminescence systems 
(Thermo Fisher Scientific) according to the manufacturer’s instructions. 
Chemiluminescence signals were detected using a CCD-based LAS-3000 imaging 
system (Fujifilm, Tokyo, Japan). Alternatively, western blot membranes were 
exposed to Hyperfilm ECL chemiluminescence films (GE Healthcare) followed by 
automated film development. 
 
Primary antibodies 
Name Dilution Type Source 
anti-HA (F-7) 1:2000 mouse monoclonal Santa Cruz Biotechnology 
anti-HA (Y-11) 1:1000 rabbit polyclonal Santa Cruz Biotechnology 
anti-Pgk1 (22C5D8) 1:15000 mouse monoclonal Thermo Fisher Scientific 
anti-Dpm1 (5C5) 1:2000 mouse monoclonal Thermo Fisher Scientific 
anti-HSP70 (BB70) 1:10000 mouse monoclonal Enzo Life Sciences 
anti-Smt3 1:10000 rabbit polyclonal Hoege et al., 2002 
anti-GST (B-14) 1:1000 mouse monoclonal 
(HRP-coupled) 
Santa Cruz Biotechnology 
 
Secondary antibodies 
Name Dilution Type Source 
goat anti-mouse 1:5000 HRP-coupled Dianova 
goat anti-rabbit 1:5000 HRP-coupled Dianova 
 
Stripping of PVDF membranes 
For incubation with alternative primary antibodies, PVDF membranes were stripped 
using the Restore Western Blot Stripping Buffer (Thermo Fisher Scientific) according 
to the manufacturer’s protocol. The membranes were washed three times for 10 min 
with TBST, incubated in blocking solution for 60 min and probed with an alternative 
primary antibody of choice. 
Analysis of HSP70 binding sites on peptide arrays 
Peptide arrays on cellulose membranes were generated using automated SPOT 
synthesis on a MultiPep peptide synthesizer (INTAVIS Bioanalytical Instruments, 
Cologne, Germany). Peptides covering the Ilv6 primary sequence were designed to 
comprise a length of 13 amino acids overlapping by 10 amino acids. 
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 Before incubation with recombinant GST-Ssa1, the membrane was washed 
for 10 min with MeOH and three times for 15 min with TBST. Subsequently, the 
membrane was blocked for 60 min with blocking solution and washed four times for 
5-10 min with TBS containing 0.05 % Tween-20. The peptide scan was then 
incubated for 90 min with 100 nM GST-Ssa1 in TBS (containing 0.05 % Tween-20) at 
room temperature followed by four 5 min washes with TBS (containing 0.05 % 
Tween-20). For the detection of GST-Ssa1 on the peptide array, the membrane was 
incubated at room temperature for 120 min with an anti-GST-HRP conjugate (B14) 
(Santa Cruz Biotechnology, Dallas, USA) in TBS (containing 0.05 % Tween-20). 
Subsequently, the membrane was washed four times for 5 min with TBST and 
subjected to chemiluminescence detection using ECL (Thermo Fisher Scientific) and 
a CCD-based LAS-3000 imaging system (Fujifilm). 
Purification of recombinant GST fusion proteins 
GST-Ssa1 was purified from E. coli cells (Rosetta) using standard protocols. In brief, 
cells were resuspended in lysis buffer (40 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM 
DTT, 1x complete EDTA-free protease inhibitor cocktail (Roche), 1 mg/ml Pefabloc 
SC (Roche)) and lysed in an EmulsiFlex-C5 homogenizer (Avestin, Ottawa, Canada). 
Lysates were then cleared by centrifugation for 30 min at 20 krpm and 4°C. 
Glutathione Sepharose 4B beads (GE Healthcare) were washed twice with dH2O, 
three times with PBS and equilibrated in lysis buffer. Subsequently, the beads were 
added to the lysates and protein binding was performed for 4 h at 4°C on a rotating 
wheel. The beads were then washed twice with lysis buffer and four times with lysis 
buffer containing 450 mM NaCl. Finally, GST-tagged proteins were eluted in four 
steps with 0.5 ml elution buffer (40 mM Tris-HCl pH 7.5, 50 mM reduced glutathione, 
5 mM DTT) and dialyzed overnight at 4°C against 5 l PBS using Slyde-A-Lyser 
dialysis cassettes (Thermo Fisher Scientific). Protein samples were frozen in liquid 
N2 and stored at -80°C. 
 
5.3.2 Microscopy techniques 
Confocal fluorescence microscopy 
To analyze the subcellular localization of GFP fusion proteins by fluorescence 
microscopy, yeast cells were grown at 30°C to exponential phase in synthetic 
complete (SC) medium. In case of import-incompetent Ilv6 variants expressed from 
the GAL1 promoter, cells were grown in raffinose-containing medium and protein 
expression was induced by addition of 2 % galactose for 60 min. The cells were then 
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transferred to a CellCarrier-96 black polystyrene microplate (Perkin Elmer, Waltham, 
USA) and stained using calcofluor white. Subsequently, images were captured using 
an OperaPhenix HCS confocal microscope (Perkin Elmer) equipped with an 
Olympus 63x water NA 1.15 objective. 
Calcofluor white staining 
To visualize yeast cells during microscopy analysis, yeast cell walls were stained by 
calcofluor white staining using a dye solution that contains 1 g/l calcofluor white and 
0.5 g/l Evans blue (Sigma-Aldrich). The solution was directly added to yeast cultures 
to a final dilution of 1:10, incubated at room temperature for at least 1 min and 
images were captured by confocal microscopy. 
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5.4 Database searches, computational analysis and software 
Literature search was performed using the PubMed search engine of the United 
States National Library of Medicine (https://www.ncbi.nlm.nih.gov/pubmed). Nucleic 
acid and protein sequence searches as well as protein domain analysis was 
performed using electronic databases of the Saccharomyces Genome Database 
(http://www.yeastgenome.org) and the UniProt consortium (http://www.uniprot.org). 
Multiple sequence alignments were assembled using the Clustal Omega webserver 
of the European Bioinformatics Institute (https://www.ebi.ac.uk/Tools/msa/clustalo).  
 For the in silico prediction of SUMO attachment sites, the GPS-SUMO 2.0 
software of the Cuckoo workgroup was used (http://sumosp.biocuckoo.org). 
Mitochondrial targeting sequences were predicted using MitoProt II 
(https://ihg.gsf.de/ihg/mitoprot.html) (Claros and Vincens, 1996) and TargetP 
(http://www.cbs.dtu.dk/services/TargetP) (Emanuelsson et al., 2000; Nielsen et al., 
1997). 
 DNA sequence analysis and in silico cloning was carried out using the 
DNASTAR Lasergene software package (DNASTAR Inc., Madison, USA). For the 
presentation of statistical data, GraphPad Prism (GraphPad Software, La Jolla, USA) 
was used. Linear adjustment of western blot contrasts and preparation of figures, 
illustrations and cartoons was performed using Adobe Photoshop and Illustrator 
(Adobe Systems Inc., San Jose, USA). ImageJ software (https://imagej.nih.gov/ij) 
was used for western blot quantification. Text processing and generation of tables 
were carried out using Microsoft Office (Microsoft Corporation, Redmond, USA). 
EndNote X7 (Thomson Reuters, New York City, USA) was used for reference 
management. 
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7 INDEX OF ABBREVIATIONS 
7.1 Abbreviations 
Ax   absorbance at x nm 
Ac   acetyl group 
ACT   aspartate kinase, chorismate mutase, TyrA 
ADP   adenosine 5’-diphosphate 
AIM   Atg8-interacting motif 
ALS_ss_C  acetolactate synthase small subunit C-terminus 
AMP   adenosine 5’-monophosphate 
ATP   adenosine 5’-triphosphate 
bp   base pair 
CHX   cycloheximide 
CPC   cysteine-proline-cysteine 
CSM   complete supplement mixture 
dNTP   2’-deoxyribonucleoside-5’-triphosphate 
DTT   dithiothreitol 
CCD   charge-coupled device 
CHIP   carboxy terminus of HSC70-interacting protein 
cl.   clone 
DMSO   dimethylsulfoxide 
DNA   deoxyribonucleic acid 
Drp1   dynamin-related protein 1 
ds   double stranded 
DUB   deubiquitylating enzyme 
E1   activating enzyme 
E2   conjugating enzyme 
E3   ligase 
ECL   enhanced chemiluminescence 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
e.g.   exempli gratia (for example) 
ER   endoplasmic reticulum 
ERAD   ER-associated degradation 
FAD   flavin adenine dinucleotide 
FAT10   human leukocyte antigen F-associated transcript 10 
FUB1   Fau ubiquitin-like protein 1 
FUS   fused in sarcoma 
G418   geneticin sulfate 
GABARAP  gamma-aminobutyric acid receptor-associated protein 
Gal   galactose 
GAP   GTPase-activating protein 
GFP   green fluorescent protein 
GLUT   glucose transporter 
GST   glutathione S-transferase 
HA   influenza hemagglutinine epitope 
HCS   high content screening 
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HDAC   histone deacetylase 
HECT   homologous to the E6-AP carboxy terminus 
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
hphNT1  gene conferring resistance to hygromycin B 
HRP   horseradish peroxidase 
HS   heat shock 
HSC   heat shock cognate 
HSP   heat shock protein 
IκB-α   nuclear factor of κ light polypeptide gene enhancer in B-cells 
   inhibitor-α 
IM   (mitochondrial) inner membrane 
IMP   (mitochondrial) inner membrane peptidase 
IMS   (mitochondrial) intermembrane space 
IPTG   isopropyl β-D-1-thiogalactopyranosid 
ISG15   interferon-stimulated gene 15 
kanMX4  gene conferring resistance to G418 
LB   lysogeny broth 
LC   liquid chromatography 
LC3   microtubule-associated protein 1A/1B light chain 3 
LIR   LC3-interacting region 
MAPL   mitochondria-anchored protein ligase 
MEF2A  myocyte-specific enhancer factor 2A 
MIA   mitochondrial intermembrane space assembly 
MOPS   3-(N-morpholino)propanesulfonic acid 
MPIB   Max Planck Institute of Biochemistry 
MPP   mitochondrial processing peptidase 
mRNA   messenger RNA 
MS   mass spectrometry 
MSF   mitochondrial import stimulation factor 
mt   mitochondrial 
MTS   mitochondrial targeting sequence 
MUL1   mitochondrial ubiquitin ligase activator of NF-κB 1 
NAT   nourseotricin 
natNT2  gene conferring resistance to nourseotricin 
NBR1   next to BRCA1 gene 1 protein 
NEDD8  neuronal-precursor-cell expressed developmentally 
   downregulated protein 8 
NEF   nucleotide exchange factor 
NEM   N-ethylmaleimide 
Ni-NTA  Ni2+-charged nitrilotriacetic acid 
NLS   nuclear localization signal 
NPC   nuclear pore complex 
NSE2   non-structural maintenance of chromosomes element 2 
   homolog 
ODx   optical density at x nm 
OM   outer (mitochondrial) membrane 
ORF   open reading frame 
OXA   cytochrome oxidase activity 
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PAGE   polyacrylamide gel electrophoresis 
PAM   presequence translocase-associated motor 
PBF   presequence binding factor 
PBS   phosphate-buffered saline 
Pc2   polycomb 2 homolog 
PCNA   proliferating cell nuclear antigen 
PCR   polymerase chain reaction 
PD   pull-down 
PEG   polyethylene glycol 
Pi   phosphate 
PIAS   protein inhibitor of activated STAT 
PIP   PCNA-interacting protein 
PPi   pyrophosphate 
PTM   posttranslational modification 
PVDF   polyvinylidene fluoride 
Ran   Ras-related nuclear protein 
RanBP2  Ran-binding protein 2 
RanGAP1  Ran GTPase-activating protein 1 
RING   really interesting new gene 
RNA   ribonucleic acid 
Rpl   ribosomal protein of the large (60S) subunit 
rpm   rounds per minute 
Rps   ribosomal protein of the small (40S) subunit 
RSUME  RWD-containing SUMOylation enhancer 
SAE   SUMO-activating enzyme 
SAF-A/B  scaffold attachment protein A/B 
SAM   sorting and assembly machinery 
SAP   SAF-A/B, Acinus, PIAS 
SC   synthetic complete 
S. cerevisiae  Saccharomyces cerevisiae 
SDS   sodium dodecyl sulfate 
SENP   sentrin-specific protease 
sHSP   small HSP 
SILAC   stable isotope labeling by amino acids in cell culture 
SIM   SUMO-interacting motif 
SP-RING  Siz/PIAS-RING 
SQSTM1  sequestosome-1 
STUbL   SUMO-targeted ubiquitin ligase 
SUMO   small ubiquitin-like modifier 
TBE   Tris, boric acid, EDTA 
TBS   Tris-buffered saline 
TBST   TBS containing 0.1 % Tween-20 
TCA   trichloroacetic acid 
TDG   thymine DNA glycosylase 
TIM   translocase of the (mitochondrial) inner membrane 
TOM   translocase of the (mitochondrial) outer membrane 
TOPORS  topoisomerase Ι-binding arginine/serine-rich protein 
TRAF7   tumor necrosis factor receptor-associated factor 7 
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Tris   Tris(hydroxymethyl)aminomethane 
Triton X-100  4-(1’,1’,3’,3’-tetramethylbutyl)phenyl polyethyleneglycol ether 
Tween-20  Polyethylene glycol sorbitan monolaurate 
Ub   ubiquitin 
UBA   ubiquitin-associated 
UBD   ubiquitin-binding domain 
UBL   ubiquitin-like 
UCH   ubiquitin C-terminal hydrolase 
UFM1   ubiquitin-fold modifier 1 
UPS   ubiquitin-proteasome system 
UV   ultraviolet 
v/v   volume per volume 
WB   western blot 
WT   wild type 
w/v   weight per volume 
YPD   yeast extract, peptone, dextrose 
ZMIZ1   zinc finger MIZ domain-containing protein 1 
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7.2 Amino acids 
 
1-letter code 3-letter code Amino acid 
A Ala Alanine 
C Cys Cysteine 
D Asp Aspartate 
E Glu Glutamic acid 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
Y Tyr Tyrosine 
 
7.3 Prefixes and units 
k kilo (103)   °C degree Celsius 
m milli (10-3)   Da Dalton 
µ micro (10-6)   g gram 
n nano (10-9)   g acceleration of gravity 
     h hour(s) 
     Hz Hertz 
     l liter 
     min minute(s) 
     M molar 
     s second(s) 
     S Svedberg 
     V Volt 
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